{"ticker": {"uuid": "2bb665ea-f020-4920-a400-e76e9382824a", "symbol": "AXGN", "name": "Axogen Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "charts": {"tiers": [{"count": 36, "label": "Direct company coverage"}, {"count": 0, "label": "Industry context"}, {"count": 0, "label": "Sector context"}], "events": [{"count": 27, "label": "Earnings"}, {"count": 5, "label": "Market update"}, {"count": 3, "label": "Analyst action"}, {"count": 1, "label": "Deals and strategy"}], "sources": [{"label": "MarketBeat", "count": 7}, {"label": "TradingView", "count": 5}, {"label": "Investing.com", "count": 4}, {"label": "Stock Titan", "count": 3}, {"label": "GuruFocus", "count": 2}, {"label": "vinanet.vn", "count": 2}, {"label": "The Manila Times", "count": 1}, {"label": "AOL.ca", "count": 1}]}, "insights": [{"text": "Early balanced news score", "tone": "neutral", "label": "Weighted tone", "value": "55/100"}, {"text": "4.96 effective stories after overlap and weighting.", "tone": "neutral", "label": "Evidence confidence", "value": "26/100"}, {"text": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.", "tone": "neutral", "label": "Market reaction", "value": "Early company-news score"}, {"text": "87/100 evidence concentration around this catalyst.", "tone": "neutral", "label": "Primary event", "value": "Earnings"}, {"text": "100% of weighted evidence is company-specific.", "tone": "positive", "label": "Company focus", "value": "36"}, {"text": "lower dispersion means the independent stories agree more closely.", "tone": "neutral", "label": "Evidence agreement", "value": "21/100"}, {"text": "+2.1% over one week, +21.9% over four weeks, trend active, and materially above fair value.", "tone": "positive", "label": "Trend context", "value": "Trend active"}, {"text": "Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference", "tone": "neutral", "label": "Latest direct headline", "value": "Neutral"}], "classifier": {"events": [{"count": 27, "event": "earnings", "label": "Earnings", "weight": 17.3}, {"count": 5, "event": "general", "label": "Market update", "weight": 3.0}, {"count": 3, "event": "analyst", "label": "Analyst action", "weight": 1.8}, {"count": 1, "event": "deals", "label": "Deals and strategy", "weight": 0.6}], "pipeline": {"status": "partial", "providers_attempted": 4, "providers_with_results": 1, "raw_articles": 71, "unique_stories": 37, "duplicates_removed": 34, "relevant_stories": 36, "matched_archive_stories": 36, "current_evidence": 17, "direct_evidence": 36, "archive_articles": 7, "durable_story_count": 36, "durable_evidence_used": true, "durable_collected_at": "2026-09-04T01:46:51.369517+00:00"}, "confidence": 87, "primary_event": "earnings", "primary_label": "Earnings", "negative_events": 8, "positive_events": 9}, "updated_at": "2026-09-04T22:52:07.390559+00:00", "total_unique": 36, "total_fetched": 36, "interpretation": {"tone": "neutral", "label": "Early company-news score", "risks": [], "badges": ["Provisional evidence"], "summary": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.", "confidence": 26, "event_label": "Earnings", "opportunities": [], "classification": "provisional", "sentiment_word": "balanced"}, "market_context": {"trend_tone": "positive", "latest_week": "2026-08-28", "trend_label": "Trend active", "latest_close": 51.47, "trend_signal": "1", "one_week_move": 2.1, "reaction_tone": "positive", "fair_value_gap": 177.7, "four_week_move": 21.9, "reaction_label": "Price confirming higher", "fair_value_tone": "negative", "market_dynamics": 0.212012, "market_sentence": "+2.1% over one week, +21.9% over four weeks, trend active, and materially above fair value.", "fair_value_label": "Materially above fair value", "twelve_week_move": 20.3, "relative_strength": 39.741301, "has_market_context": true, "expectation_direction": "positive", "expectation_probability": 59.6547, "market_dynamics_buy_signal": false}, "total_relevant": 36, "pipeline_health": {"status": "partial", "providers_attempted": 4, "providers_with_results": 1, "raw_articles": 71, "unique_stories": 37, "duplicates_removed": 34, "relevant_stories": 36, "matched_archive_stories": 36, "current_evidence": 17, "direct_evidence": 36, "archive_articles": 7, "durable_story_count": 36, "durable_evidence_used": true, "durable_collected_at": "2026-09-04T22:52:07.390559+00:00"}, "sentiment_summary": {"tone": "neutral", "label": "Early balanced news score", "score": 55, "total": 36, "neutral": 19, "negative": 8, "positive": 9, "raw_score": 68, "confidence": 26, "dispersion": 21, "story_count": 36, "window_days": 30, "direct_share": 100, "source_count": 10, "score_version": "evidence-v10", "evidence_count": 17, "evidence_status": "provisional", "information_mass": 0.385, "weighting_method": "event-aware exponential freshness decay", "newest_article_at": "2026-09-01T11:01:02+00:00", "direct_story_count": 36, "effective_articles": 4.96, "sector_story_count": 0, "direct_source_count": 10, "industry_story_count": 0, "source_concentration": 0.2611, "directional_story_count": 17}, "articles": [{"url": "https://www.manilatimes.net/2026/09/01/tmt-newswire/globenewswire/axogen-inc-to-participate-in-the-24th-annual-morgan-stanley-global-healthcare-conference/2415867", "tier": "direct", "title": "Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference", "topics": ["Finance", "Life Sciences"], "summary": "Axogen, Inc. (NASDAQ: AXGN) announced its participation in the 24th Annual Morgan Stanley Global Healthcare Conference. Management will be available for one-on-one investor meetings on Tuesday, September 15, 2026. Axogen specializes in developing and marketing surgical solutions for peripheral nerve function restoration.", "age_days": 3.5, "is_stale": false, "sentiment": "neutral", "event_type": "general", "tier_label": "Direct company coverage", "event_label": "Market update", "source_kind": "publisher", "source_link": "https://www.manilatimes.net/2026/09/01/tmt-newswire/globenewswire/axogen-inc-to-participate-in-the-24th-annual-morgan-stanley-global-healthcare-conference/2415867", "source_name": "The Manila Times", "published_at": "2026-09-01T11:01:02", "tone_signals": [], "company_focus": 0.78, "freshness_pct": 29.8, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 2, "evidence_weight": 0.014253, "influence_label": "None", "event_confidence": 35, "company_focus_pct": 78, "evidence_strength": 0, "published_display": "01 Sep 2026 11:01", "direction_included": false, "company_focus_label": "Shared story", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://www.investing.com/news/company-news/axogen-stock-hits-52week-high-at-5113-usd-93CH-4877719", "tier": "direct", "title": "Axogen stock hits 52-week high at 51.13 USD", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Axogen Inc.'s stock reached a new 52-week high of $51.13, reflecting a remarkable 214.19% increase over the past year. Despite this growth and positive revenue figures, an InvestingPro tip suggests the stock might be overvalued. Analysts have raised price targets, highlighting the company's strong market position and growth prospects in the peripheral nerve repair market.", "age_days": 8.2, "is_stale": false, "sentiment": "neutral", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.investing.com/news/company-news/axogen-stock-hits-52week-high-at-5113-usd-93CH-4877719", "source_name": "Investing.com", "published_at": "2026-08-27T17:01:02", "tone_signals": ["Operating growth", "Negative valuation view"], "company_focus": 1.0, "freshness_pct": 31.9, "sentiment_pct": 54, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.06877, "influence_label": "None", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "27 Aug 2026 17:01", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://www.investing.com/news/analyst-ratings/truist-initiates-axogen-stock-with-buy-rating-on-growth-potential-93CH-4876590", "tier": "direct", "title": "Truist initiates AxoGen stock with buy rating on growth potential", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Truist Securities has initiated coverage on AxoGen, Inc. (NASDAQ:AXGN) with a buy rating and a $60.00 price target, citing the company's strong position in the peripheral nerve repair market and its potential for sustained double-digit growth. The firm projects revenue growth above 20% through 2029, with AxoGen outperforming the IHI index over the last twelve months. This positive outlook follows AxoGen's strong Q2 2026 financial results, which showed significant revenue growth and met adjusted EPS expectations.", "age_days": 9.2, "is_stale": false, "sentiment": "positive", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.investing.com/news/analyst-ratings/truist-initiates-axogen-stock-with-buy-rating-on-growth-potential-93CH-4876590", "source_name": "Investing.com", "published_at": "2026-08-26T17:01:02", "tone_signals": ["Analyst upgrade", "Beat expectations", "Buy Rating", "Operating growth"], "company_focus": 1.0, "freshness_pct": 27.8, "sentiment_pct": 84, "evidence_basis": "archived_article", "evidence_share": 39.9, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.153896, "influence_label": "High", "event_confidence": 69, "company_focus_pct": 100, "evidence_strength": 69, "published_display": "26 Aug 2026 17:01", "direction_included": true, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "39.9"}, {"url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFB6ejdDdWNGVFduUUtpYUc2dUx6N1lCMzUtdGN5T2pkb2pPNm94cTAta05PRFFOLXZtSnl0cjNUY21EY2gwaldobmJLVmRBUXdwSElJWmRPR0dhVUh2UnNJRENmT0h2X0l1eU51ajhDTnRUUk1PNGFpZy0wWQ?oc=5", "tier": "direct", "title": "Axogen (AXGN) Q2 2026 Earnings Call Transcript", "topics": [], "summary": "", "age_days": 10.3, "is_stale": false, "sentiment": "neutral", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://news.google.com/rss/articles/CBMie0FVX3lxTFB6ejdDdWNGVFduUUtpYUc2dUx6N1lCMzUtdGN5T2pkb2pPNm94cTAta05PRFFOLXZtSnl0cjNUY21EY2gwaldobmJLVmRBUXdwSElJWmRPR0dhVUh2UnNJRENmT0h2X0l1eU51ajhDTnRUUk1PNGFpZy0wWQ?oc=5", "source_name": "AOL.ca", "published_at": "2026-08-25T15:19:02+00:00", "tone_signals": [], "company_focus": 1.0, "freshness_pct": 23.9, "sentiment_pct": 50, "evidence_basis": "headline_only", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.01969, "influence_label": "None", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "25 Aug 2026 15:19", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1Jd3JyOU1CMVhmczdkNU9BbC13OEdNaklRLU9ybVhNNTVzY090WVRiQmFXWjl5bGk0VElYQ2oyN0pvRnU3Ni12akRRT3NCQzZ1ZTNxcFRBd1RKRnJadno1WHhwQXhIZw?oc=5", "tier": "direct", "title": "Axogen Inc (MEX:AXGN) Stock Price, Trades & News", "topics": [], "summary": "", "age_days": 12.1, "is_stale": false, "sentiment": "neutral", "event_type": "general", "tier_label": "Direct company coverage", "event_label": "Market update", "source_kind": "publisher", "source_link": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1Jd3JyOU1CMVhmczdkNU9BbC13OEdNaklRLU9ybVhNNTVzY090WVRiQmFXWjl5bGk0VElYQ2oyN0pvRnU3Ni12akRRT3NCQzZ1ZTNxcFRBd1RKRnJadno1WHhwQXhIZw?oc=5", "source_name": "GuruFocus", "published_at": "2026-08-23T20:40:42+00:00", "tone_signals": [], "company_focus": 1.0, "freshness_pct": 1.5, "sentiment_pct": 50, "evidence_basis": "headline_only", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.00081, "influence_label": "None", "event_confidence": 35, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "23 Aug 2026 20:40", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://news.google.com/rss/articles/CBMinwJBVV95cUxOLS1xMmtjUktmSlJ6Q19rV2dtYTBkX3Z5STNsSzYtRG5HY2s1SGd5bkQxT19RSWNET2t1TXI0WGlWRFJrYV9acF8ybm9Rd3VVNjlBZWYyWF8waEkxWGNocHRWSFpxWmtJX21TUUJBN2dLT2lmWmFEemdHUjRwcnFmaURubUlESnNJSFA1RVNCT1ByOTNqZVQ4OGc5S2EtWncydWJ1NVpveTA1NjkyckZjQXRVZS13OTFSV3dHVUIwSnhaQTVGSkV1MGMwMU90dFhsWTFGa3pyemxLMjBRMnBnaTFVVXpQdkl1ZkJsZl9ITnRFTnNuekg3em8tM3RmU1dFUm1oMVgwRUtXRl9FNHBwcXRhZHlFME5OZzZBTFBBUQ?oc=5", "tier": "direct", "title": "Axogen (AXGN) Results Breakdown: The Available Earnings Metric Delivers a Miss for This Review; Market Response: Shares Move Higher 8.53% in the Latest Session - Earnings Season Review", "topics": [], "summary": "", "age_days": 12.3, "is_stale": false, "sentiment": "negative", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://news.google.com/rss/articles/CBMinwJBVV95cUxOLS1xMmtjUktmSlJ6Q19rV2dtYTBkX3Z5STNsSzYtRG5HY2s1SGd5bkQxT19RSWNET2t1TXI0WGlWRFJrYV9acF8ybm9Rd3VVNjlBZWYyWF8waEkxWGNocHRWSFpxWmtJX21TUUJBN2dLT2lmWmFEemdHUjRwcnFmaURubUlESnNJSFA1RVNCT1ByOTNqZVQ4OGc5S2EtWncydWJ1NVpveTA1NjkyckZjQXRVZS13OTFSV3dHVUIwSnhaQTVGSkV1MGMwMU90dFhsWTFGa3pyemxLMjBRMnBnaTFVVXpQdkl1ZkJsZl9ITnRFTnNuekg3em8tM3RmU1dFUm1oMVgwRUtXRl9FNHBwcXRhZHlFME5OZzZBTFBBUQ?oc=5", "source_name": "vinanet.vn", "published_at": "2026-08-23T15:36:25+00:00", "tone_signals": ["Missed expectations"], "company_focus": 1.0, "freshness_pct": 18.2, "sentiment_pct": 25, "evidence_basis": "headline_only", "evidence_share": 10.1, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.038834, "influence_label": "Medium", "event_confidence": 61, "company_focus_pct": 100, "evidence_strength": 55, "published_display": "23 Aug 2026 15:36", "direction_included": true, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "10.1"}, {"url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE10ejRnOTBtQi1heWNEY1EzNmpFVkw0cUtZb0MzenViRUhNdi1CLUVOT1VfNjdqb0ltYjR2R3lmNGtGS3hSdTNUQURhaFYzRlQ1dk5MQmhvaS1fS0ZMTkhoUjR3?oc=5", "tier": "direct", "title": "Axogen Inc (MEX:AXGN) Stock Earnings Transcripts", "topics": [], "summary": "", "age_days": 12.4, "is_stale": false, "sentiment": "neutral", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE10ejRnOTBtQi1heWNEY1EzNmpFVkw0cUtZb0MzenViRUhNdi1CLUVOT1VfNjdqb0ltYjR2R3lmNGtGS3hSdTNUQURhaFYzRlQ1dk5MQmhvaS1fS0ZMTkhoUjR3?oc=5", "source_name": "GuruFocus", "published_at": "2026-08-23T13:21:04+00:00", "tone_signals": [], "company_focus": 1.0, "freshness_pct": 17.9, "sentiment_pct": 50, "evidence_basis": "headline_only", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.014754, "influence_label": "None", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "23 Aug 2026 13:21", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://www.easternprogress.com/axogen-axgn-tops-q2-earnings-and-revenue-estimates/article_4721b3f3-0210-5f07-8c2a-8150f4935373.html", "tier": "direct", "title": "AxoGen (AXGN) Tops Q2 Earnings and Revenue Estimates", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "AxoGen (AXGN) reported strong Q2 earnings, surpassing Zacks Consensus Estimates for both earnings per share and revenue. The company posted $0.12 EPS against an estimated $0.09 and revenues of $69.73 million, exceeding the $66.85 million estimate. While the stock currently holds a Zacks Rank #3 (Hold), investors are anticipating management's future commentary and upcoming earnings estimates.", "age_days": 13.2, "is_stale": false, "sentiment": "positive", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.easternprogress.com/axogen-axgn-tops-q2-earnings-and-revenue-estimates/article_4721b3f3-0210-5f07-8c2a-8150f4935373.html", "source_name": "Eastern Progress", "published_at": "2026-08-22T17:44:40", "tone_signals": ["Beat expectations", "Operating growth"], "company_focus": 1.0, "freshness_pct": 16.0, "sentiment_pct": 78, "evidence_basis": "archived_article", "evidence_share": 12.8, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.049148, "influence_label": "High", "event_confidence": 61, "company_focus_pct": 100, "evidence_strength": 59, "published_display": "22 Aug 2026 17:44", "direction_included": true, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "12.8"}, {"url": "https://timothysykes.com/news/axogeninc-axgn-news-2026_08_22", "tier": "direct", "title": "AXGN Jumps As Axogen Wins Wave Of Price Target Hikes", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Axogen Inc. (AXGN) stock jumped 8.53% after its Q2 2026 revenue exceeded expectations and management raised its full-year revenue outlook. Several firms, including Canaccord and Jefferies, subsequently increased their price targets on AXGN to the $53-$55 range, reiterating Buy or Outperform ratings. The company's strong performance was driven by breast procedure growth, high gross margins, and a solid balance sheet with positive free cash flow.", "age_days": 13.3, "is_stale": false, "sentiment": "positive", "event_type": "analyst", "tier_label": "Direct company coverage", "event_label": "Analyst action", "source_kind": "publisher", "source_link": "https://timothysykes.com/news/axogeninc-axgn-news-2026_08_22", "source_name": "Timothy Sykes", "published_at": "2026-08-22T15:05:00", "tone_signals": ["Beat expectations", "Guidance raised", "Improving financial comparison", "Positive market reaction"], "company_focus": 1.0, "freshness_pct": 4.6, "sentiment_pct": 79, "evidence_basis": "archived_article", "evidence_share": 3.6, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.013763, "influence_label": "Medium", "event_confidence": 85, "company_focus_pct": 100, "evidence_strength": 55, "published_display": "22 Aug 2026 15:05", "direction_included": true, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "3.6"}, {"url": "https://stockstotrade.com/news/axogeninc-axgn-news-2026_08_22", "tier": "direct", "title": "Axogen Stock Climbs As Analysts Hike Price Targets After Q2 Beat", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Axogen Inc. (AXGN) stock climbed over 8.5% after beating Q2 2026 revenue expectations and raising its full-year guidance. Analysts from multiple firms have increased their price targets for AXGN to $53-$55, maintaining Buy or Outperform ratings. Despite strong top-line growth and gross margins, the company reported a small net loss due to high operating costs, but maintains a strong balance sheet with no debt.", "age_days": 13.4, "is_stale": false, "sentiment": "positive", "event_type": "analyst", "tier_label": "Direct company coverage", "event_label": "Analyst action", "source_kind": "publisher", "source_link": "https://stockstotrade.com/news/axogeninc-axgn-news-2026_08_22", "source_name": "StocksToTrade", "published_at": "2026-08-22T12:40:46", "tone_signals": ["Positive market reaction", "Improving financial comparison", "Operating growth", "Large positive market reaction"], "company_focus": 1.0, "freshness_pct": 4.5, "sentiment_pct": 80, "evidence_basis": "archived_article", "evidence_share": 3.5, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.013632, "influence_label": "Medium", "event_confidence": 77, "company_focus_pct": 100, "evidence_strength": 56, "published_display": "22 Aug 2026 12:40", "direction_included": true, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "3.5"}, {"url": "https://www.tradingview.com/symbols/BMV-AXGN/financials-statistics-and-ratios/operating-margin", "tier": "direct", "title": "Operating margin % of Axogen, Inc. \u2013 BMV:AXGN", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "The article focuses on the operating margin percentage of Axogen, Inc. (BMV:AXGN), a company listed on the Mexican Stock Exchange under the Health Technology sector. It appears to be a financial data page from TradingView, indicating that the market for this stock was closed with no trades. The core content highlights the company's operating margin, period value, and changes.", "age_days": 14.3, "is_stale": false, "sentiment": "neutral", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.tradingview.com/symbols/BMV-AXGN/financials-statistics-and-ratios/operating-margin", "source_name": "TradingView", "published_at": "2026-08-21T14:40:46", "tone_signals": [], "company_focus": 1.0, "freshness_pct": 13.7, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.013148, "influence_label": "None", "event_confidence": 61, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "21 Aug 2026 14:40", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://www.tradingview.com/symbols/BMV-AXGN/financials-statistics-and-ratios/price-sales", "tier": "direct", "title": "Price to sales ratio of Axogen, Inc. \u2013 BMV:AXGN", "topics": ["Financial Markets", "Life Sciences"], "summary": "This page provides financial information for Axogen, Inc. (BMV:AXGN) on TradingView, specifically focusing on its Price to Sales ratio. It indicates that the market for AXGN is currently closed with no trades. The content also lists various features and services offered by TradingView.", "age_days": 14.5, "is_stale": false, "sentiment": "neutral", "event_type": "general", "tier_label": "Direct company coverage", "event_label": "Market update", "source_kind": "publisher", "source_link": "https://www.tradingview.com/symbols/BMV-AXGN/financials-statistics-and-ratios/price-sales", "source_name": "TradingView", "published_at": "2026-08-21T11:11:59", "tone_signals": [], "company_focus": 1.0, "freshness_pct": 0.7, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.000412, "influence_label": "None", "event_confidence": 35, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "21 Aug 2026 11:11", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://www.marketbeat.com/instant-alerts/filing-31800-shares-in-axogen-inc-axgn-bought-by-edmond-de-rothschild-holding-sa-2026-08-21", "tier": "direct", "title": "31,800 Shares in AxoGen, Inc. $AXGN Bought by Edmond DE Rothschild Holding S.A.", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Edmond DE Rothschild Holding S.A. has acquired a new stake of 31,800 shares in AxoGen, Inc. (NASDAQ:AXGN) during the second quarter, valued at approximately $1,469,000. Other institutional investors like BlackRock Inc. and Deutsche Bank AG also increased their holdings. This comes as AxoGen reported strong Q2 earnings, meeting consensus estimates, despite recent insider stock sales.", "age_days": 14.6, "is_stale": false, "sentiment": "positive", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.marketbeat.com/instant-alerts/filing-31800-shares-in-axogen-inc-axgn-bought-by-edmond-de-rothschild-holding-sa-2026-08-21", "source_name": "MarketBeat", "published_at": "2026-08-21T08:41:02", "tone_signals": ["Institutional or insider buying", "Operating growth"], "company_focus": 1.0, "freshness_pct": 13.2, "sentiment_pct": 64, "evidence_basis": "archived_article", "evidence_share": 8.7, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.033533, "influence_label": "Medium", "event_confidence": 61, "company_focus_pct": 100, "evidence_strength": 45, "published_display": "21 Aug 2026 08:41", "direction_included": true, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "8.7"}, {"url": "https://www.tradingview.com/symbols/BIVA-AXGN/financials-cash-flow", "tier": "direct", "title": "Axogen, Inc. Cash Flow \u2013 BIVA:AXGN", "topics": ["Earnings", "Finance"], "summary": "Axogen, Inc. (BIVA:AXGN) reported its Q2 2026 free cash flow at 110.76 million MXN, a significant improvement from -52.88 million MXN in 2025. The company's operating cash flow for 2025 was 14.64 million MXN. The article provides a high-level overview of the company's cash flow activities for recent years.", "age_days": 15.1, "is_stale": false, "sentiment": "neutral", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.tradingview.com/symbols/BIVA-AXGN/financials-cash-flow", "source_name": "TradingView", "published_at": "2026-08-20T20:41:02", "tone_signals": [], "company_focus": 1.0, "freshness_pct": 12.3, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.01185, "influence_label": "None", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "20 Aug 2026 20:41", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://www.tradingview.com/symbols/BMV-AXGN/financials-balance-sheet/total-assets", "tier": "direct", "title": "Total assets of Axogen, Inc. \u2013 BMV:AXGN", "topics": ["Financial Markets", "Life Sciences"], "summary": "This page from TradingView provides financial information for Axogen, Inc. (BMV:AXGN), specifically focusing on its total assets. The article indicates that the market was closed and no trades were made at the time of publication, and it highlights the availability of historical data for the company's assets.", "age_days": 15.1, "is_stale": false, "sentiment": "neutral", "event_type": "general", "tier_label": "Direct company coverage", "event_label": "Market update", "source_kind": "publisher", "source_link": "https://www.tradingview.com/symbols/BMV-AXGN/financials-balance-sheet/total-assets", "source_name": "TradingView", "published_at": "2026-08-20T19:41:02", "tone_signals": [], "company_focus": 1.0, "freshness_pct": 0.5, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.000282, "influence_label": "None", "event_confidence": 35, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "20 Aug 2026 19:41", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://www.tradingview.com/symbols/BIVA-AXGN?solution=43000699498", "tier": "direct", "title": "AXGN Stock Price and Chart \u2014 BIVA:AXGN", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "This page provides a comprehensive overview of Axogen, Inc. (AXGN) stock, traded on BIVA. It includes key financial stats such as market capitalization, revenue, and EPS, along with company information and employee data. The article also features analyst ratings, investment ideas, and details on ETFs holding Axogen stock, offering a complete picture for potential investors.", "age_days": 15.2, "is_stale": false, "sentiment": "neutral", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.tradingview.com/symbols/BIVA-AXGN?solution=43000699498", "source_name": "TradingView", "published_at": "2026-08-20T17:10:16", "tone_signals": [], "company_focus": 1.0, "freshness_pct": 12.1, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.011612, "influence_label": "None", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "20 Aug 2026 17:10", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://www.marketbeat.com/instant-alerts/filing-tocqueville-asset-management-lp-takes-803-million-position-in-axogen-inc-axgn-2026-08-20", "tier": "direct", "title": "Tocqueville Asset Management L.P. Takes $8.03 Million Position in AxoGen, Inc. $AXGN", "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "summary": "Tocqueville Asset Management L.P. has acquired a new position in AxoGen, Inc. (NASDAQ:AXGN), purchasing 173,900 shares valued at approximately $8.03 million. Despite institutional investors owning over 80% of the company and a \"Moderate Buy\" consensus rating from analysts, AxoGen remains unprofitable, with insiders selling significant amounts of stock. The company recently reported quarterly revenue of $69.73 million and adjusted earnings of $0.12 per share, matching earnings expectations while exceeding revenue estimates.", "age_days": 15.5, "is_stale": false, "sentiment": "neutral", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.marketbeat.com/instant-alerts/filing-tocqueville-asset-management-lp-takes-803-million-position-in-axogen-inc-axgn-2026-08-20", "source_name": "MarketBeat", "published_at": "2026-08-20T10:10:16", "tone_signals": ["Institutional or insider buying"], "company_focus": 1.0, "freshness_pct": 11.6, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.014664, "influence_label": "None", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "20 Aug 2026 10:10", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://www.investing.com/news/company-news/axogen-stock-reaches-52week-high-at-500-usd-93CH-4865553", "tier": "direct", "title": "Axogen stock reaches 52-week high at 50.0 USD", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Axogen Inc. (AXGN) has reached a new 52-week high of $50.00, reflecting a 222.92% growth over the past year and strong market sentiment. Despite this achievement, InvestingPro analysis suggests the stock is overvalued. The company recently reported significant revenue growth of 23% in Q2 2026, surpassing analyst estimates, leading to increased price targets from H.C. Wainwright and Citizens.", "age_days": 17.4, "is_stale": false, "sentiment": "neutral", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.investing.com/news/company-news/axogen-stock-reaches-52week-high-at-500-usd-93CH-4865553", "source_name": "Investing.com", "published_at": "2026-08-18T13:39:50", "tone_signals": ["Operating growth", "Negative valuation view"], "company_focus": 1.0, "freshness_pct": 9.0, "sentiment_pct": 53, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.01651, "influence_label": "None", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "18 Aug 2026 13:39", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://www.marketbeat.com/instant-alerts/filing-rice-hall-james-associates-llc-invests-341-million-in-axogen-inc-axgn-2026-08-18", "tier": "direct", "title": "Rice Hall James & Associates LLC Invests $3.41 Million in AxoGen, Inc. $AXGN", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Rice Hall James & Associates LLC acquired a new stake of 73,903 shares in AxoGen, Inc. ($AXGN) during the second quarter, valued at approximately $3.41 million. Institutional investors collectively own 80.29% of AxoGen, while insider activity shows recent sales totaling $4.48 million. Analysts maintain a \"Moderate Buy\" rating for AxoGen with an average target price of $51.00, following the company's Q2 earnings report which met EPS estimates and exceeded revenue expectations.", "age_days": 17.5, "is_stale": false, "sentiment": "positive", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.marketbeat.com/instant-alerts/filing-rice-hall-james-associates-llc-invests-341-million-in-axogen-inc-axgn-2026-08-18", "source_name": "MarketBeat", "published_at": "2026-08-18T10:39:50", "tone_signals": ["Beat expectations", "Institutional or insider buying"], "company_focus": 1.0, "freshness_pct": 8.8, "sentiment_pct": 61, "evidence_basis": "archived_article", "evidence_share": 4.7, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.017922, "influence_label": "Medium", "event_confidence": 69, "company_focus_pct": 100, "evidence_strength": 39, "published_display": "18 Aug 2026 10:39", "direction_included": true, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "4.7"}, {"url": "https://www.marketbeat.com/instant-alerts/filing-689833-shares-in-axogen-inc-axgn-bought-by-timessquare-capital-management-llc-2026-08-18", "tier": "direct", "title": "689,833 Shares in AxoGen, Inc. $AXGN Bought by TimesSquare Capital Management LLC", "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "summary": "TimesSquare Capital Management LLC has acquired 689,833 shares of AxoGen, Inc. (NASDAQ:AXGN) worth approximately $31.9 million, representing a 1.28% stake in the medical equipment provider. This move contributes to the 80.29% institutional ownership of the company. Despite recent insider selling, analysts maintain a \"Moderate Buy\" rating for AxoGen, with a consensus price target of $51.", "age_days": 17.6, "is_stale": false, "sentiment": "positive", "event_type": "analyst", "tier_label": "Direct company coverage", "event_label": "Analyst action", "source_kind": "publisher", "source_link": "https://www.marketbeat.com/instant-alerts/filing-689833-shares-in-axogen-inc-axgn-bought-by-timessquare-capital-management-llc-2026-08-18", "source_name": "MarketBeat", "published_at": "2026-08-18T09:39:50", "tone_signals": ["Institutional or insider buying"], "company_focus": 1.0, "freshness_pct": 1.7, "sentiment_pct": 60, "evidence_basis": "archived_article", "evidence_share": 0.7, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.002746, "influence_label": "Low", "event_confidence": 61, "company_focus_pct": 100, "evidence_strength": 33, "published_display": "18 Aug 2026 09:39", "direction_included": true, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0.7"}, {"url": "https://m.investing.com/news/insider-trading-news/axogen-director-amy-wendell-sells-646k-in-shares-93CH-4861808?ampMode=1", "tier": "direct", "title": "Axogen director Amy Wendell sells $646k in shares", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Axogen director Amy Wendell sold approximately $646,592 worth of common stock on August 11, 2026, following the exercise of employee stock options. This sale, conducted via a Rule 10b5-1 trading plan, occurred as the stock traded near its 52-week high, despite an InvestingPro analysis suggesting it might be overvalued. The company recently reported strong Q2 2026 revenue growth, exceeding Wall Street estimates, and received raised price targets from analysts.", "age_days": 20.3, "is_stale": false, "sentiment": "negative", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://m.investing.com/news/insider-trading-news/axogen-director-amy-wendell-sells-646k-in-shares-93CH-4861808?ampMode=1", "source_name": "Investing.com", "published_at": "2026-08-15T15:42:31", "tone_signals": ["Institutional or insider selling", "Negative valuation view"], "company_focus": 1.0, "freshness_pct": 6.0, "sentiment_pct": 42, "evidence_basis": "archived_article", "evidence_share": 3.6, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.013993, "influence_label": "Low", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 35, "published_display": "15 Aug 2026 15:42", "direction_included": true, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "3.6"}, {"url": "https://www.stocktitan.net/sec-filings/AXGN/schedule-13g-a-axogen-inc-amended-passive-investment-disclosure-73b59a4d36b4.html", "tier": "direct", "title": "First Light Asset Management (AXGN) discloses 7.58% Axogen stake for Mathew Arens", "topics": ["Financial Markets", "Life Sciences"], "summary": "First Light Asset Management, LLC and Mathew P. Arens have filed an amended Schedule 13G disclosing their beneficial ownership in Axogen, Inc. First Light Asset Management may be deemed to beneficially own 3,746,380 shares (6.97% of the class), while Mathew P. Arens may be deemed to beneficially own 4,072,910 shares (7.58% of the class). Arens's ownership includes shares controlled through the Manager, direct holdings, and a joint account.", "age_days": 21.1, "is_stale": false, "sentiment": "neutral", "event_type": "deals", "tier_label": "Direct company coverage", "event_label": "Deals and strategy", "source_kind": "publisher", "source_link": "https://www.stocktitan.net/sec-filings/AXGN/schedule-13g-a-axogen-inc-amended-passive-investment-disclosure-73b59a4d36b4.html", "source_name": "Stock Titan", "published_at": "2026-08-14T20:41:19", "tone_signals": [], "company_focus": 1.0, "freshness_pct": 12.4, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.010703, "influence_label": "None", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "14 Aug 2026 20:41", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5QTEpYRmtoYzFUbnF6WElMU1NoeUhwVGhNZkRQNWhOOFVuRGN4N1FoQ19kdml4SlNXNU53R01EUHNEZTRoQXp2bzFkSUczd05SZFd5b2NBRk1Sc2V6V3dWOW52LVN5WkJGWm8tYmJoeUdpRlFGRlEydG9VaU4?oc=5", "tier": "direct", "title": "Axogen (AXGN) Q2 2026 Earnings Call Transcript", "topics": [], "summary": "", "age_days": 22.0, "is_stale": false, "sentiment": "neutral", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5QTEpYRmtoYzFUbnF6WElMU1NoeUhwVGhNZkRQNWhOOFVuRGN4N1FoQ19kdml4SlNXNU53R01EUHNEZTRoQXp2bzFkSUczd05SZFd5b2NBRk1Sc2V6V3dWOW52LVN5WkJGWm8tYmJoeUdpRlFGRlEydG9VaU4?oc=5", "source_name": "AOL.com", "published_at": "2026-08-13T22:13:47+00:00", "tone_signals": [], "company_focus": 1.0, "freshness_pct": 4.7, "sentiment_pct": 50, "evidence_basis": "headline_only", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.003883, "influence_label": "None", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "13 Aug 2026 22:13", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://www.marketbeat.com/instant-alerts/filing-axogen-inc-axgn-shares-sold-by-wasatch-advisors-lp-2026-08-12", "tier": "direct", "title": "AxoGen, Inc. $AXGN Shares Sold by Wasatch Advisors LP", "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "summary": "Wasatch Advisors LP has reduced its stake in AxoGen, Inc. by 30.2%, selling over 560,000 shares but still retaining 1.30 million shares valued at approximately $59.9 million. Despite this sale, institutional investors collectively own 80.29% of the company, and analyst sentiment remains positive with a \"Moderate Buy\" consensus rating. AxoGen recently reported quarterly revenue of $69.73 million and adjusted earnings of $0.12 per share, meeting EPS estimates and exceeding revenue expectations.", "age_days": 22.9, "is_stale": false, "sentiment": "negative", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.marketbeat.com/instant-alerts/filing-axogen-inc-axgn-shares-sold-by-wasatch-advisors-lp-2026-08-12", "source_name": "MarketBeat", "published_at": "2026-08-13T02:11:02", "tone_signals": ["Institutional or insider selling"], "company_focus": 1.0, "freshness_pct": 4.2, "sentiment_pct": 42, "evidence_basis": "archived_article", "evidence_share": 2.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.007552, "influence_label": "Low", "event_confidence": 69, "company_focus_pct": 100, "evidence_strength": 34, "published_display": "13 Aug 2026 02:11", "direction_included": true, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "2"}, {"url": "https://www.marketbeat.com/instant-alerts/axogen-nasdaqaxgn-director-sells-64655226-in-stock-2026-08-12", "tier": "direct", "title": "AxoGen (NASDAQ:AXGN) Director Sells $646,552.26 in Stock", "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "summary": "AxoGen Director Amy McBride Wendell sold 13,353 shares of AXGN stock for over $646,000, reducing her total holdings by 11.01%. This sale occurred under a pre-arranged Rule 10b5-1 plan, and comes as AxoGen shares traded up 2.5% to $49.67, near their 52-week high, following strong earnings that met EPS expectations and exceeded revenue estimates.", "age_days": 23.0, "is_stale": false, "sentiment": "negative", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.marketbeat.com/instant-alerts/axogen-nasdaqaxgn-director-sells-64655226-in-stock-2026-08-12", "source_name": "MarketBeat", "published_at": "2026-08-12T21:41:35", "tone_signals": ["Institutional or insider selling"], "company_focus": 1.0, "freshness_pct": 4.1, "sentiment_pct": 42, "evidence_basis": "archived_article", "evidence_share": 1.9, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.007371, "influence_label": "Low", "event_confidence": 93, "company_focus_pct": 100, "evidence_strength": 34, "published_display": "12 Aug 2026 21:41", "direction_included": true, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "1.9"}, {"url": "https://www.marketbeat.com/instant-alerts/axogen-nasdaqaxgn-evp-marc-began-sells-67500-shares-of-stock-2026-08-12", "tier": "direct", "title": "AxoGen (NASDAQ:AXGN) EVP Marc Began Sells 67,500 Shares of Stock", "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "summary": "AxoGen EVP Marc Began sold 67,500 shares of company stock for approximately $3.20 million, reducing his direct holdings by over 57%. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan. Despite the insider sale, AxoGen shares rose, nearing their 52-week high, and the company reported strong quarterly results that met earnings expectations and exceeded revenue estimates.", "age_days": 23.0, "is_stale": false, "sentiment": "negative", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.marketbeat.com/instant-alerts/axogen-nasdaqaxgn-evp-marc-began-sells-67500-shares-of-stock-2026-08-12", "source_name": "MarketBeat", "published_at": "2026-08-12T21:41:35", "tone_signals": ["Institutional or insider selling"], "company_focus": 1.0, "freshness_pct": 4.1, "sentiment_pct": 42, "evidence_basis": "archived_article", "evidence_share": 1.8, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.007116, "influence_label": "Low", "event_confidence": 69, "company_focus_pct": 100, "evidence_strength": 34, "published_display": "12 Aug 2026 21:41", "direction_included": true, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "1.8"}, {"url": "https://www.marketscreener.com/news/axogen-insider-sold-shares-worth-3-195-788-according-to-a-recent-sec-filing-ce7859d8d18bfe26", "tier": "direct", "title": "Axogen Insider Sold Shares Worth $3,195,788, According to a Recent SEC Filing", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "An insider at Axogen (AXGN) sold shares valued at $3,195,788, as disclosed in a recent SEC filing. This transaction follows another reported insider sale of $646,592 on the same day. Axogen specializes in technologies for peripheral nerve regeneration and repair.", "age_days": 23.1, "is_stale": false, "sentiment": "negative", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.marketscreener.com/news/axogen-insider-sold-shares-worth-3-195-788-according-to-a-recent-sec-filing-ce7859d8d18bfe26", "source_name": "www.marketscreener.com", "published_at": "2026-08-12T20:41:12", "tone_signals": ["Institutional or insider selling"], "company_focus": 1.0, "freshness_pct": 4.1, "sentiment_pct": 40, "evidence_basis": "archived_article", "evidence_share": 2.1, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.008062, "influence_label": "Medium", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 36, "published_display": "12 Aug 2026 20:41", "direction_included": true, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "2.1"}, {"url": "https://www.stocktitan.net/sec-filings/AXGN/144-axogen-inc-sec-filing-eaf13d04bf65.html", "tier": "direct", "title": "Axogen, Inc. SEC Filing (Aug 11, 2026)", "topics": ["Earnings", "Finance", "Life Sciences"], "summary": "This article reports on an SEC Form 144 filing by Axogen, Inc. (AXGN) on August 11, 2026, detailing a proposed sale of 13,353 common shares with an aggregate market value of $643,881.66 through Morgan Stanley Smith Barney LLC. The securities were acquired on the same date through the exercise of stock options. The filing indicates a neutral impact and sentiment according to AI analysis.", "age_days": 24.0, "is_stale": false, "sentiment": "neutral", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.stocktitan.net/sec-filings/AXGN/144-axogen-inc-sec-filing-eaf13d04bf65.html", "source_name": "Stock Titan", "published_at": "2026-08-11T22:41:35", "tone_signals": [], "company_focus": 1.0, "freshness_pct": 3.6, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 2, "evidence_weight": 0.003443, "influence_label": "None", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "11 Aug 2026 22:41", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://simplywall.st/stocks/us/healthcare/nasdaq-axgn/axogen/news/axogen-axgn-is-up-54-after-raising-2026-revenue-outlook-desp/amp", "tier": "direct", "title": "Axogen (AXGN) Is Up 5.4% After Raising 2026 Revenue Outlook Despite Ongoing Losses \u2013 Has The Bull Case Changed?", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Axogen (AXGN) reported higher Q2 2026 revenue of US$69.73 million but increased net losses of US$1.52 million. Despite ongoing losses, the company raised its full-year 2026 revenue outlook to at least US$279 million, leading to a 5.4% stock increase. This updated guidance reinforces the company's growth story in nerve repair solutions, though investors should consider risks like reliance on a single product and regulatory pressures.", "age_days": 24.3, "is_stale": false, "sentiment": "negative", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://simplywall.st/stocks/us/healthcare/nasdaq-axgn/axogen/news/axogen-axgn-is-up-54-after-raising-2026-revenue-outlook-desp/amp", "source_name": "Simply Wall Street", "published_at": "2026-08-11T16:39:40", "tone_signals": ["Positive financial language"], "company_focus": 0.78, "freshness_pct": 3.5, "sentiment_pct": 42, "evidence_basis": "archived_article", "evidence_share": 1.1, "score_included": true, "duplicate_count": 2, "evidence_weight": 0.004167, "influence_label": "Low", "event_confidence": 61, "company_focus_pct": 78, "evidence_strength": 30, "published_display": "11 Aug 2026 16:39", "direction_included": true, "company_focus_label": "Shared story", "source_link_is_lookup": false, "evidence_share_display": "1.1"}, {"url": "https://ca.investing.com/news/stock-market-news/axogen-stock-hits-52week-high-at-4709-usd-93CH-4789947", "tier": "direct", "title": "Axogen stock hits 52-week high at 47.09 USD By Investing.com", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Axogen Inc. (AXGN) stock reached a new 52-week high of $47.09, trading at $47.11 with a market capitalization of $2.52 billion, representing a 231.91% surge over the past year. InvestingPro analysis indicates the stock is currently overvalued, yet net income is projected to grow, with analysts forecasting profitability. Recent Q2 2026 financial results showed revenue of $69.7 million, exceeding estimates, and analysts have raised price targets for the company.", "age_days": 25.4, "is_stale": false, "sentiment": "neutral", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://ca.investing.com/news/stock-market-news/axogen-stock-hits-52week-high-at-4709-usd-93CH-4789947", "source_name": "Investing.com Canada", "published_at": "2026-08-10T14:11:49", "tone_signals": ["Negative valuation view"], "company_focus": 1.0, "freshness_pct": 3.0, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 2, "evidence_weight": 0.004953, "influence_label": "None", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "10 Aug 2026 14:11", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://news.google.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?oc=5", "tier": "direct", "title": "Is Axogen (AXGN) Still Below Fair Value As Strong Q2 Results Lift Guidance?", "topics": [], "summary": "", "age_days": 25.7, "is_stale": false, "sentiment": "positive", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-08-10T07:00:00+00:00", "tone_signals": ["Guidance raised"], "company_focus": 1.0, "freshness_pct": 2.9, "sentiment_pct": 79, "evidence_basis": "headline_only", "evidence_share": 1.8, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.006761, "influence_label": "Medium", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 55, "published_display": "10 Aug 2026 07:00", "direction_included": true, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "1.8"}, {"url": "https://www.tradingkey.com/markets/stocks/axgn/news", "tier": "direct", "title": "AxoGen Inc (AXGN) Stock News Today", "topics": ["Financial Markets", "Life Sciences"], "summary": "This article provides an overview of AxoGen Inc (AXGN) stock, including its current price, market capitalization, and a note that more", "age_days": 27.3, "is_stale": false, "sentiment": "neutral", "event_type": "general", "tier_label": "Direct company coverage", "event_label": "Market update", "source_kind": "publisher", "source_link": "https://www.tradingkey.com/markets/stocks/axgn/news", "source_name": "TradingKey", "published_at": "2026-08-08T16:11:49", "tone_signals": [], "company_focus": 1.0, "freshness_pct": 0.0, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 5e-06, "influence_label": "None", "event_confidence": 35, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "08 Aug 2026 16:11", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://www.theglobeandmail.com/investing/markets/stocks/AXGN-Q/pressreleases/3730971/axogen-axgn-q2-2026-earnings-call-transcript", "tier": "direct", "title": "Axogen (AXGN) Q2 2026 Earnings Call Transcript", "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "summary": "Axogen (AXGN) reported strong Q2 2026 financial results with revenue up 23.1% year-over-year, driven primarily by significant growth in its Breast segment. The company raised its full-year revenue guidance to at least $279 million, reflecting confidence in its commercial execution and sales force productivity, though it revised its gross margin guidance to at least 73% due to a shift in product mix towards higher-cost breast procedures. Axogen also highlighted strategic investments in imaging technology and ongoing clinical development in prostate repair, emphasizing its commitment to expanding peripheral nerve care.", "age_days": 28.0, "is_stale": false, "sentiment": "positive", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.theglobeandmail.com/investing/markets/stocks/AXGN-Q/pressreleases/3730971/axogen-axgn-q2-2026-earnings-call-transcript", "source_name": "The Globe and Mail", "published_at": "2026-08-07T23:40:13", "tone_signals": ["Guidance raised"], "company_focus": 0.78, "freshness_pct": 2.1, "sentiment_pct": 60, "evidence_basis": "archived_article", "evidence_share": 0.7, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.002796, "influence_label": "Low", "event_confidence": 69, "company_focus_pct": 78, "evidence_strength": 32, "published_display": "07 Aug 2026 23:40", "direction_included": true, "company_focus_label": "Shared story", "source_link_is_lookup": false, "evidence_share_display": "0.7"}, {"url": "https://www.stocktitan.net/sec-filings/AXGN/144-axogen-inc-sec-filing-dbcdf13fb5f0.html", "tier": "direct", "title": "Axogen, Inc. SEC Filing (Aug 7, 2026)", "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "summary": "This article reports on an SEC Form 144 filing by Axogen, Inc. (AXGN) on August 7, 2026. The filing indicates a proposed sale of 14,150 shares with an aggregate market value of $627,552.50, acquired through Restricted Stock Units on June 19, 2026. The filing also notes that 53,761,513 shares are outstanding and the sale is anticipated to occur on NASDAQ.", "age_days": 28.1, "is_stale": false, "sentiment": "neutral", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.stocktitan.net/sec-filings/AXGN/144-axogen-inc-sec-filing-dbcdf13fb5f0.html", "source_name": "Stock Titan", "published_at": "2026-08-07T20:11:08", "tone_signals": [], "company_focus": 1.0, "freshness_pct": 2.0, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.001949, "influence_label": "None", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "07 Aug 2026 20:11", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://www.reveliolabs.com/companies/axogen/employees", "tier": "direct", "title": "AxoGen Number of Employees 2026 | Employee Count & Headcount Data", "topics": ["Earnings", "Life Sciences"], "summary": "AxoGen (NASDAQ: AXGN) has 652 employees globally as of March 2026, marking a 36.7% growth since 2023. The company is actively hiring with 57 job postings in 2026, and its workforce is primarily concentrated in North America. Despite growth, overall employee sentiment is negative and declining, and the average salary is $112,705.", "age_days": 28.3, "is_stale": false, "sentiment": "neutral", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.reveliolabs.com/companies/axogen/employees", "source_name": "Revelio Labs", "published_at": "2026-08-07T15:42:35", "tone_signals": ["Negative financial language"], "company_focus": 1.0, "freshness_pct": 2.0, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.002141, "influence_label": "None", "event_confidence": 53, "company_focus_pct": 100, "evidence_strength": 0, "published_display": "07 Aug 2026 15:42", "direction_included": false, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0"}, {"url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNeTJoYTNzZzBrZ1BEU2FTWDlpZlN3M0c2ekdIazFCU2Rtc2JWbDRkNm52OTNGZEI4Mk9oVDFMZzMwWFhCX0d0RmFXaktKam5DSWFNOWtpU3pUX192bEIwcXM1MlFLcElPN1dlWFhmQUtnYUxYS0tBaFAxdWxGZjBvaFZTNDFOUS12WlBfakp0TXNVSFN4WE95Zmp1aXIyRjFUQmFyVzE3ZUhmQkExd2lF?oc=5", "tier": "direct", "title": "AXGN Q2 2026 Earnings: EPS of $0.12 Edges Below Consensus, Shares Dip 1.92% - Earnings Quality Analysis", "topics": [], "summary": "", "age_days": 28.7, "is_stale": false, "sentiment": "negative", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNeTJoYTNzZzBrZ1BEU2FTWDlpZlN3M0c2ekdIazFCU2Rtc2JWbDRkNm52OTNGZEI4Mk9oVDFMZzMwWFhCX0d0RmFXaktKam5DSWFNOWtpU3pUX192bEIwcXM1MlFLcElPN1dlWFhmQUtnYUxYS0tBaFAxdWxGZjBvaFZTNDFOUS12WlBfakp0TXNVSFN4WE95Zmp1aXIyRjFUQmFyVzE3ZUhmQkExd2lF?oc=5", "source_name": "vinanet.vn", "published_at": "2026-08-07T07:00:00+00:00", "tone_signals": ["Missed expectations"], "company_focus": 1.0, "freshness_pct": 1.9, "sentiment_pct": 25, "evidence_basis": "headline_only", "evidence_share": 1.0, "score_included": true, "duplicate_count": 1, "evidence_weight": 0.004021, "influence_label": "Medium", "event_confidence": 61, "company_focus_pct": 100, "evidence_strength": 51, "published_display": "07 Aug 2026 07:00", "direction_included": true, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "1"}], "by_tier": {"direct": [{"url": "https://www.manilatimes.net/2026/09/01/tmt-newswire/globenewswire/axogen-inc-to-participate-in-the-24th-annual-morgan-stanley-global-healthcare-conference/2415867", "tier": "direct", "title": "Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference", "topics": ["Finance", "Life Sciences"], "summary": "Axogen, Inc. (NASDAQ: AXGN) announced its participation in the 24th Annual Morgan Stanley Global Healthcare Conference. Management will be available for one-on-one investor meetings on Tuesday, September 15, 2026. Axogen specializes in developing and marketing surgical solutions for peripheral nerve function restoration.", "age_days": 3.5, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "neutral", "story_key": "13412ecc0fba69a132437dba840cf75974f883a219d1ad012a9610ac86b1890b", "event_type": "general", "tier_label": "Direct company coverage", "event_label": "Market update", "source_kind": "publisher", "source_link": "https://www.manilatimes.net/2026/09/01/tmt-newswire/globenewswire/axogen-inc-to-participate-in-the-24th-annual-morgan-stanley-global-healthcare-conference/2415867", "source_name": "The Manila Times", "published_at": "2026-09-01T11:01:02", "source_names": ["The Manila Times"], "target_scope": "Axogen, Inc. Axogen, Inc. (NASDAQ: AXGN) announced its participation in the 24th Annual Morgan Stanley Global Healthcare Conference. Axogen specializes in developing and marketing surgical solutions for peripheral nerve function restoration.", "tone_signals": [], "company_focus": 0.78, "cross_listing": false, "entity_mapped": true, "freshness_pct": 29.8, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 2, "durable_archive": false, "evidence_weight": 0.014253, "influence_label": "None", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 35, "model_confidence": 0.4, "provider_symbols": ["AXGN", "AXGN.ARCHIVE", "MS"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 78, "evidence_strength": 0, "published_display": "01 Sep 2026 11:01", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Shared story", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.1051}, {"url": "https://www.investing.com/news/company-news/axogen-stock-hits-52week-high-at-5113-usd-93CH-4877719", "tier": "direct", "title": "Axogen stock hits 52-week high at 51.13 USD", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Axogen Inc.'s stock reached a new 52-week high of $51.13, reflecting a remarkable 214.19% increase over the past year. Despite this growth and positive revenue figures, an InvestingPro tip suggests the stock might be overvalued. Analysts have raised price targets, highlighting the company's strong market position and growth prospects in the peripheral nerve repair market.", "age_days": 8.2, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "neutral", "story_key": "ea9893f351b61a44fef86af49e880b45408995479bc9e66d015bd1a503ed7e50", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.investing.com/news/company-news/axogen-stock-hits-52week-high-at-5113-usd-93CH-4877719", "source_name": "Investing.com", "published_at": "2026-08-27T17:01:02", "source_names": ["Investing.com"], "target_scope": "Axogen stock hits 52-week high at 51.13 USD Axogen Inc.'s stock reached a new 52-week high of $51.13, reflecting a remarkable 214.19% increase over the past year.", "tone_signals": ["Operating growth", "Negative valuation view"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 31.9, "sentiment_pct": 54, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.06877, "influence_label": "None", "provider_symbol": "", "relevance_score": 0.988293, "archive_provider": "", "event_confidence": 53, "model_confidence": 0.595, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "27 Aug 2026 17:01", "direction_included": false, "sentiment_conflict": 0.27, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.4433}, {"url": "https://www.investing.com/news/analyst-ratings/truist-initiates-axogen-stock-with-buy-rating-on-growth-potential-93CH-4876590", "tier": "direct", "title": "Truist initiates AxoGen stock with buy rating on growth potential", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Truist Securities has initiated coverage on AxoGen, Inc. (NASDAQ:AXGN) with a buy rating and a $60.00 price target, citing the company's strong position in the peripheral nerve repair market and its potential for sustained double-digit growth. The firm projects revenue growth above 20% through 2029, with AxoGen outperforming the IHI index over the last twelve months. This positive outlook follows AxoGen's strong Q2 2026 financial results, which showed significant revenue growth and met adjusted EPS expectations.", "age_days": 9.2, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "positive", "story_key": "98e09a3f0d577553fcd1bad265d5a6c26296256c0707fcf4d4e97b8cd5c5cfef", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.investing.com/news/analyst-ratings/truist-initiates-axogen-stock-with-buy-rating-on-growth-potential-93CH-4876590", "source_name": "Investing.com", "published_at": "2026-08-26T17:01:02", "source_names": ["Investing.com"], "target_scope": "Truist initiates AxoGen stock with buy rating on growth potential Truist Securities has initiated coverage on AxoGen, Inc. (NASDAQ:AXGN) with a buy rating and a $60.00 price target, citing the company's strong position in the peripheral nerve repair market and its potential for sustained double-digit growth. The firm projects revenue growth above 20% through 2029, with AxoGen outperforming the IHI index over the last twelve months. This positive outlook follows AxoGen's strong Q2 2026 financial results, which showed significant revenue growth and met adjusted EPS expectations.", "tone_signals": ["Analyst upgrade", "Beat expectations", "Buy Rating", "Operating growth"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 27.8, "sentiment_pct": 84, "evidence_basis": "archived_article", "evidence_share": 39.9, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.153896, "influence_label": "High", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 69, "model_confidence": 0.84, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 69, "published_display": "26 Aug 2026 17:01", "direction_included": true, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "39.9", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.4227}, {"url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFB6ejdDdWNGVFduUUtpYUc2dUx6N1lCMzUtdGN5T2pkb2pPNm94cTAta05PRFFOLXZtSnl0cjNUY21EY2gwaldobmJLVmRBUXdwSElJWmRPR0dhVUh2UnNJRENmT0h2X0l1eU51ajhDTnRUUk1PNGFpZy0wWQ?oc=5", "tier": "direct", "title": "Axogen (AXGN) Q2 2026 Earnings Call Transcript", "topics": [], "summary": "", "age_days": 10.3, "is_stale": false, "provider": "archive", "providers": ["archive"], "sentiment": "neutral", "story_key": "6869d72b06db85e5d04c007c9e87d13cf9b603d61f160bb959659c25d01b4854", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://news.google.com/rss/articles/CBMie0FVX3lxTFB6ejdDdWNGVFduUUtpYUc2dUx6N1lCMzUtdGN5T2pkb2pPNm94cTAta05PRFFOLXZtSnl0cjNUY21EY2gwaldobmJLVmRBUXdwSElJWmRPR0dhVUh2UnNJRENmT0h2X0l1eU51ajhDTnRUUk1PNGFpZy0wWQ?oc=5", "source_name": "AOL.ca", "published_at": "2026-08-25T15:19:02+00:00", "source_names": ["AOL.ca"], "target_scope": "Axogen (AXGN) Q2 2026 Earnings Call Transcript", "tone_signals": [], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 23.9, "sentiment_pct": 50, "evidence_basis": "headline_only", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": true, "evidence_weight": 0.01969, "influence_label": "None", "provider_symbol": "", "relevance_score": 0.78, "archive_provider": "google_news", "event_confidence": 53, "model_confidence": 0.4, "provider_symbols": ["AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "25 Aug 2026 15:19", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN.ARCHIVE", "provider_directional_mass": null}, {"url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1Jd3JyOU1CMVhmczdkNU9BbC13OEdNaklRLU9ybVhNNTVzY090WVRiQmFXWjl5bGk0VElYQ2oyN0pvRnU3Ni12akRRT3NCQzZ1ZTNxcFRBd1RKRnJadno1WHhwQXhIZw?oc=5", "tier": "direct", "title": "Axogen Inc (MEX:AXGN) Stock Price, Trades & News", "topics": [], "summary": "", "age_days": 12.1, "is_stale": false, "provider": "archive", "providers": ["archive"], "sentiment": "neutral", "story_key": "de9188c265a4996f0de73a1a244f43c62a0058b2efd1945fd8df5f92ccc4b6a7", "event_type": "general", "tier_label": "Direct company coverage", "event_label": "Market update", "source_kind": "publisher", "source_link": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1Jd3JyOU1CMVhmczdkNU9BbC13OEdNaklRLU9ybVhNNTVzY090WVRiQmFXWjl5bGk0VElYQ2oyN0pvRnU3Ni12akRRT3NCQzZ1ZTNxcFRBd1RKRnJadno1WHhwQXhIZw?oc=5", "source_name": "GuruFocus", "published_at": "2026-08-23T20:40:42+00:00", "source_names": ["GuruFocus"], "target_scope": "Axogen Inc (MEX:AXGN) Stock Price, Trades & News", "tone_signals": [], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 1.5, "sentiment_pct": 50, "evidence_basis": "headline_only", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": true, "evidence_weight": 0.00081, "influence_label": "None", "provider_symbol": "", "relevance_score": 0.78, "archive_provider": "google_news", "event_confidence": 35, "model_confidence": 0.4, "provider_symbols": ["AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "23 Aug 2026 20:40", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN.ARCHIVE", "provider_directional_mass": null}, {"url": "https://news.google.com/rss/articles/CBMinwJBVV95cUxOLS1xMmtjUktmSlJ6Q19rV2dtYTBkX3Z5STNsSzYtRG5HY2s1SGd5bkQxT19RSWNET2t1TXI0WGlWRFJrYV9acF8ybm9Rd3VVNjlBZWYyWF8waEkxWGNocHRWSFpxWmtJX21TUUJBN2dLT2lmWmFEemdHUjRwcnFmaURubUlESnNJSFA1RVNCT1ByOTNqZVQ4OGc5S2EtWncydWJ1NVpveTA1NjkyckZjQXRVZS13OTFSV3dHVUIwSnhaQTVGSkV1MGMwMU90dFhsWTFGa3pyemxLMjBRMnBnaTFVVXpQdkl1ZkJsZl9ITnRFTnNuekg3em8tM3RmU1dFUm1oMVgwRUtXRl9FNHBwcXRhZHlFME5OZzZBTFBBUQ?oc=5", "tier": "direct", "title": "Axogen (AXGN) Results Breakdown: The Available Earnings Metric Delivers a Miss for This Review; Market Response: Shares Move Higher 8.53% in the Latest Session - Earnings Season Review", "topics": [], "summary": "", "age_days": 12.3, "is_stale": false, "provider": "archive", "providers": ["archive"], "sentiment": "negative", "story_key": "49c6e473fac9e6e744360820ba61dc39f75d1b5244423bbc9a92846a618d524a", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://news.google.com/rss/articles/CBMinwJBVV95cUxOLS1xMmtjUktmSlJ6Q19rV2dtYTBkX3Z5STNsSzYtRG5HY2s1SGd5bkQxT19RSWNET2t1TXI0WGlWRFJrYV9acF8ybm9Rd3VVNjlBZWYyWF8waEkxWGNocHRWSFpxWmtJX21TUUJBN2dLT2lmWmFEemdHUjRwcnFmaURubUlESnNJSFA1RVNCT1ByOTNqZVQ4OGc5S2EtWncydWJ1NVpveTA1NjkyckZjQXRVZS13OTFSV3dHVUIwSnhaQTVGSkV1MGMwMU90dFhsWTFGa3pyemxLMjBRMnBnaTFVVXpQdkl1ZkJsZl9ITnRFTnNuekg3em8tM3RmU1dFUm1oMVgwRUtXRl9FNHBwcXRhZHlFME5OZzZBTFBBUQ?oc=5", "source_name": "vinanet.vn", "published_at": "2026-08-23T15:36:25+00:00", "source_names": ["vinanet.vn"], "target_scope": "Axogen (AXGN) Results Breakdown: The Available Earnings Metric Delivers a Miss for This Review", "tone_signals": ["Missed expectations"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 18.2, "sentiment_pct": 25, "evidence_basis": "headline_only", "evidence_share": 10.1, "score_included": true, "duplicate_count": 1, "durable_archive": true, "evidence_weight": 0.038834, "influence_label": "Medium", "provider_symbol": "", "relevance_score": 0.78, "archive_provider": "google_news", "event_confidence": 61, "model_confidence": 0.59, "provider_symbols": ["AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 55, "published_display": "23 Aug 2026 15:36", "direction_included": true, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "10.1", "target_provider_symbol": "AXGN.ARCHIVE", "provider_directional_mass": null}, {"url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE10ejRnOTBtQi1heWNEY1EzNmpFVkw0cUtZb0MzenViRUhNdi1CLUVOT1VfNjdqb0ltYjR2R3lmNGtGS3hSdTNUQURhaFYzRlQ1dk5MQmhvaS1fS0ZMTkhoUjR3?oc=5", "tier": "direct", "title": "Axogen Inc (MEX:AXGN) Stock Earnings Transcripts", "topics": [], "summary": "", "age_days": 12.4, "is_stale": false, "provider": "archive", "providers": ["archive"], "sentiment": "neutral", "story_key": "6080752a87fc844770afef6feae80802eacc605a3b1485a0feb05c72a2ecc194", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE10ejRnOTBtQi1heWNEY1EzNmpFVkw0cUtZb0MzenViRUhNdi1CLUVOT1VfNjdqb0ltYjR2R3lmNGtGS3hSdTNUQURhaFYzRlQ1dk5MQmhvaS1fS0ZMTkhoUjR3?oc=5", "source_name": "GuruFocus", "published_at": "2026-08-23T13:21:04+00:00", "source_names": ["GuruFocus"], "target_scope": "Axogen Inc (MEX:AXGN) Stock Earnings Transcripts", "tone_signals": [], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 17.9, "sentiment_pct": 50, "evidence_basis": "headline_only", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": true, "evidence_weight": 0.014754, "influence_label": "None", "provider_symbol": "", "relevance_score": 0.78, "archive_provider": "google_news", "event_confidence": 53, "model_confidence": 0.4, "provider_symbols": ["AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "23 Aug 2026 13:21", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN.ARCHIVE", "provider_directional_mass": null}, {"url": "https://www.easternprogress.com/axogen-axgn-tops-q2-earnings-and-revenue-estimates/article_4721b3f3-0210-5f07-8c2a-8150f4935373.html", "tier": "direct", "title": "AxoGen (AXGN) Tops Q2 Earnings and Revenue Estimates", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "AxoGen (AXGN) reported strong Q2 earnings, surpassing Zacks Consensus Estimates for both earnings per share and revenue. The company posted $0.12 EPS against an estimated $0.09 and revenues of $69.73 million, exceeding the $66.85 million estimate. While the stock currently holds a Zacks Rank #3 (Hold), investors are anticipating management's future commentary and upcoming earnings estimates.", "age_days": 13.2, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "positive", "story_key": "611c87b5c74ecc6529f7b105629ce53c29c86defbf8db9f6f0029a441185264d", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.easternprogress.com/axogen-axgn-tops-q2-earnings-and-revenue-estimates/article_4721b3f3-0210-5f07-8c2a-8150f4935373.html", "source_name": "Eastern Progress", "published_at": "2026-08-22T17:44:40", "source_names": ["Eastern Progress"], "target_scope": "AxoGen (AXGN) Tops Q2 Earnings and Revenue Estimates AxoGen (AXGN) reported strong Q2 earnings, surpassing Zacks Consensus Estimates for both earnings per share and revenue.", "tone_signals": ["Beat expectations", "Operating growth"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 16.0, "sentiment_pct": 78, "evidence_basis": "archived_article", "evidence_share": 12.8, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.049148, "influence_label": "High", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 61, "model_confidence": 0.692, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 59, "published_display": "22 Aug 2026 17:44", "direction_included": true, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "12.8", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.4889}, {"url": "https://timothysykes.com/news/axogeninc-axgn-news-2026_08_22", "tier": "direct", "title": "AXGN Jumps As Axogen Wins Wave Of Price Target Hikes", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Axogen Inc. (AXGN) stock jumped 8.53% after its Q2 2026 revenue exceeded expectations and management raised its full-year revenue outlook. Several firms, including Canaccord and Jefferies, subsequently increased their price targets on AXGN to the $53-$55 range, reiterating Buy or Outperform ratings. The company's strong performance was driven by breast procedure growth, high gross margins, and a solid balance sheet with positive free cash flow.", "age_days": 13.3, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "positive", "story_key": "91ca90083a5ef5d2f240092d0931a67394eec8cbed05a7bd3c12e750ac1a4d19", "event_type": "analyst", "tier_label": "Direct company coverage", "event_label": "Analyst action", "source_kind": "publisher", "source_link": "https://timothysykes.com/news/axogeninc-axgn-news-2026_08_22", "source_name": "Timothy Sykes", "published_at": "2026-08-22T15:05:00", "source_names": ["Timothy Sykes"], "target_scope": "AXGN Jumps As Axogen Wins Wave Of Price Target Hikes Axogen Inc. (AXGN) stock jumped 8.53% after its Q2 2026 revenue exceeded expectations and management raised its full-year revenue outlook. Several firms, including Canaccord and Jefferies, subsequently increased their price targets on AXGN to the $53-$55 range, reiterating Buy or Outperform ratings.", "tone_signals": ["Beat expectations", "Guidance raised", "Improving financial comparison", "Positive market reaction"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 4.6, "sentiment_pct": 79, "evidence_basis": "archived_article", "evidence_share": 3.6, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.013763, "influence_label": "Medium", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 85, "model_confidence": 0.831, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 55, "published_display": "22 Aug 2026 15:05", "direction_included": true, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "3.6", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.4582}, {"url": "https://stockstotrade.com/news/axogeninc-axgn-news-2026_08_22", "tier": "direct", "title": "Axogen Stock Climbs As Analysts Hike Price Targets After Q2 Beat", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Axogen Inc. (AXGN) stock climbed over 8.5% after beating Q2 2026 revenue expectations and raising its full-year guidance. Analysts from multiple firms have increased their price targets for AXGN to $53-$55, maintaining Buy or Outperform ratings. Despite strong top-line growth and gross margins, the company reported a small net loss due to high operating costs, but maintains a strong balance sheet with no debt.", "age_days": 13.4, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "positive", "story_key": "8b400d112fae0acbe81408485326af204653bdc91411f18eef01c0d3e855e96f", "event_type": "analyst", "tier_label": "Direct company coverage", "event_label": "Analyst action", "source_kind": "publisher", "source_link": "https://stockstotrade.com/news/axogeninc-axgn-news-2026_08_22", "source_name": "StocksToTrade", "published_at": "2026-08-22T12:40:46", "source_names": ["StocksToTrade"], "target_scope": "Axogen Stock Climbs As Analysts Hike Price Targets After Q2 Beat Axogen Inc. (AXGN) stock climbed over 8.5% after beating Q2 2026 revenue expectations and raising its full-year guidance. Analysts from multiple firms have increased their price targets for AXGN to $53-$55, maintaining Buy or Outperform ratings.", "tone_signals": ["Positive market reaction", "Improving financial comparison", "Operating growth", "Large positive market reaction"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 4.5, "sentiment_pct": 80, "evidence_basis": "archived_article", "evidence_share": 3.5, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.013632, "influence_label": "Medium", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 77, "model_confidence": 0.837, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 56, "published_display": "22 Aug 2026 12:40", "direction_included": true, "sentiment_conflict": 0.065, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "3.5", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.6301}, {"url": "https://www.tradingview.com/symbols/BMV-AXGN/financials-statistics-and-ratios/operating-margin", "tier": "direct", "title": "Operating margin % of Axogen, Inc. \u2013 BMV:AXGN", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "The article focuses on the operating margin percentage of Axogen, Inc. (BMV:AXGN), a company listed on the Mexican Stock Exchange under the Health Technology sector. It appears to be a financial data page from TradingView, indicating that the market for this stock was closed with no trades. The core content highlights the company's operating margin, period value, and changes.", "age_days": 14.3, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "neutral", "story_key": "3c004e9d341dbdb092e99e188ac217ea0d503da8bf8cfe645142b222b9891c7f", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.tradingview.com/symbols/BMV-AXGN/financials-statistics-and-ratios/operating-margin", "source_name": "TradingView", "published_at": "2026-08-21T14:40:46", "source_names": ["TradingView"], "target_scope": "Operating margin % of Axogen, Inc. \u2013 BMV:AXGN The article focuses on the operating margin percentage of Axogen, Inc. (BMV:AXGN), a company listed on the Mexican Stock Exchange under the Health Technology sector.", "tone_signals": [], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 13.7, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.013148, "influence_label": "None", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 61, "model_confidence": 0.4, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "21 Aug 2026 14:40", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.0296}, {"url": "https://www.tradingview.com/symbols/BMV-AXGN/financials-statistics-and-ratios/price-sales", "tier": "direct", "title": "Price to sales ratio of Axogen, Inc. \u2013 BMV:AXGN", "topics": ["Financial Markets", "Life Sciences"], "summary": "This page provides financial information for Axogen, Inc. (BMV:AXGN) on TradingView, specifically focusing on its Price to Sales ratio. It indicates that the market for AXGN is currently closed with no trades. The content also lists various features and services offered by TradingView.", "age_days": 14.5, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "neutral", "story_key": "f2903954433078c65af8c71dd11fba7bfe42164e11a7df1c7fa6dabdf0d48b86", "event_type": "general", "tier_label": "Direct company coverage", "event_label": "Market update", "source_kind": "publisher", "source_link": "https://www.tradingview.com/symbols/BMV-AXGN/financials-statistics-and-ratios/price-sales", "source_name": "TradingView", "published_at": "2026-08-21T11:11:59", "source_names": ["TradingView"], "target_scope": "Price to sales ratio of Axogen, Inc. \u2013 BMV:AXGN This page provides financial information for Axogen, Inc. (BMV:AXGN) on TradingView, specifically focusing on its Price to Sales ratio. It indicates that the market for AXGN is currently closed with no trades.", "tone_signals": [], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 0.7, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.000412, "influence_label": "None", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 35, "model_confidence": 0.4, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "21 Aug 2026 11:11", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.0621}, {"url": "https://www.marketbeat.com/instant-alerts/filing-31800-shares-in-axogen-inc-axgn-bought-by-edmond-de-rothschild-holding-sa-2026-08-21", "tier": "direct", "title": "31,800 Shares in AxoGen, Inc. $AXGN Bought by Edmond DE Rothschild Holding S.A.", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Edmond DE Rothschild Holding S.A. has acquired a new stake of 31,800 shares in AxoGen, Inc. (NASDAQ:AXGN) during the second quarter, valued at approximately $1,469,000. Other institutional investors like BlackRock Inc. and Deutsche Bank AG also increased their holdings. This comes as AxoGen reported strong Q2 earnings, meeting consensus estimates, despite recent insider stock sales.", "age_days": 14.6, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "positive", "story_key": "b79b1153e4a18df2626e3a9c48b522c797c9da1ce573551eac5f3874d46201c8", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.marketbeat.com/instant-alerts/filing-31800-shares-in-axogen-inc-axgn-bought-by-edmond-de-rothschild-holding-sa-2026-08-21", "source_name": "MarketBeat", "published_at": "2026-08-21T08:41:02", "source_names": ["MarketBeat"], "target_scope": "31,800 Shares in AxoGen, Inc. $AXGN Bought by Edmond DE Rothschild Holding S.A. has acquired a new stake of 31,800 shares in AxoGen, Inc. (NASDAQ:AXGN) during the second quarter, valued at approximately $1,469,000. This comes as AxoGen reported strong Q2 earnings, meeting consensus estimates, despite recent insider stock sales.", "tone_signals": ["Institutional or insider buying", "Operating growth"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 13.2, "sentiment_pct": 64, "evidence_basis": "archived_article", "evidence_share": 8.7, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.033533, "influence_label": "Medium", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 61, "model_confidence": 0.736, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 45, "published_display": "21 Aug 2026 08:41", "direction_included": true, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "8.7", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.4126}, {"url": "https://www.tradingview.com/symbols/BIVA-AXGN/financials-cash-flow", "tier": "direct", "title": "Axogen, Inc. Cash Flow \u2013 BIVA:AXGN", "topics": ["Earnings", "Finance"], "summary": "Axogen, Inc. (BIVA:AXGN) reported its Q2 2026 free cash flow at 110.76 million MXN, a significant improvement from -52.88 million MXN in 2025. The company's operating cash flow for 2025 was 14.64 million MXN. The article provides a high-level overview of the company's cash flow activities for recent years.", "age_days": 15.1, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "neutral", "story_key": "6cd63306c5a0346af6c05e68ebd726c53f50ad4cdba1dcc292a9323a2a467c66", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.tradingview.com/symbols/BIVA-AXGN/financials-cash-flow", "source_name": "TradingView", "published_at": "2026-08-20T20:41:02", "source_names": ["TradingView"], "target_scope": "Axogen, Inc. Cash Flow \u2013 BIVA:AXGN Axogen, Inc. (BIVA:AXGN) reported its Q2 2026 free cash flow at 110.76 million MXN, a significant improvement from -52.88 million MXN in 2025.", "tone_signals": [], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 12.3, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.01185, "influence_label": "None", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 53, "model_confidence": 0.4, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "20 Aug 2026 20:41", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.1359}, {"url": "https://www.tradingview.com/symbols/BMV-AXGN/financials-balance-sheet/total-assets", "tier": "direct", "title": "Total assets of Axogen, Inc. \u2013 BMV:AXGN", "topics": ["Financial Markets", "Life Sciences"], "summary": "This page from TradingView provides financial information for Axogen, Inc. (BMV:AXGN), specifically focusing on its total assets. The article indicates that the market was closed and no trades were made at the time of publication, and it highlights the availability of historical data for the company's assets.", "age_days": 15.1, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "neutral", "story_key": "d6f6dc71bd06cf08334dfa8dee308aa9e79b2da22aecb9818362a2c2b0d7d784", "event_type": "general", "tier_label": "Direct company coverage", "event_label": "Market update", "source_kind": "publisher", "source_link": "https://www.tradingview.com/symbols/BMV-AXGN/financials-balance-sheet/total-assets", "source_name": "TradingView", "published_at": "2026-08-20T19:41:02", "source_names": ["TradingView"], "target_scope": "Total assets of Axogen, Inc. \u2013 BMV:AXGN This page from TradingView provides financial information for Axogen, Inc. (BMV:AXGN), specifically focusing on its total assets.", "tone_signals": [], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 0.5, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.000282, "influence_label": "None", "provider_symbol": "", "relevance_score": 0.78, "archive_provider": "", "event_confidence": 35, "model_confidence": 0.4, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "20 Aug 2026 19:41", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.0276}, {"url": "https://www.tradingview.com/symbols/BIVA-AXGN?solution=43000699498", "tier": "direct", "title": "AXGN Stock Price and Chart \u2014 BIVA:AXGN", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "This page provides a comprehensive overview of Axogen, Inc. (AXGN) stock, traded on BIVA. It includes key financial stats such as market capitalization, revenue, and EPS, along with company information and employee data. The article also features analyst ratings, investment ideas, and details on ETFs holding Axogen stock, offering a complete picture for potential investors.", "age_days": 15.2, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "neutral", "story_key": "c64499688ef3cd37d34c1b462a73f6ae7b50711b1564fc93fa734b14e89623d4", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.tradingview.com/symbols/BIVA-AXGN?solution=43000699498", "source_name": "TradingView", "published_at": "2026-08-20T17:10:16", "source_names": ["TradingView"], "target_scope": "AXGN Stock Price and Chart \u2014 BIVA:AXGN This page provides a comprehensive overview of Axogen, Inc. (AXGN) stock, traded on BIVA. The article also features analyst ratings, investment ideas, and details on ETFs holding Axogen stock, offering a complete picture for potential investors.", "tone_signals": [], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 12.1, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.011612, "influence_label": "None", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 53, "model_confidence": 0.4, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "20 Aug 2026 17:10", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.1934}, {"url": "https://www.marketbeat.com/instant-alerts/filing-tocqueville-asset-management-lp-takes-803-million-position-in-axogen-inc-axgn-2026-08-20", "tier": "direct", "title": "Tocqueville Asset Management L.P. Takes $8.03 Million Position in AxoGen, Inc. $AXGN", "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "summary": "Tocqueville Asset Management L.P. has acquired a new position in AxoGen, Inc. (NASDAQ:AXGN), purchasing 173,900 shares valued at approximately $8.03 million. Despite institutional investors owning over 80% of the company and a \"Moderate Buy\" consensus rating from analysts, AxoGen remains unprofitable, with insiders selling significant amounts of stock. The company recently reported quarterly revenue of $69.73 million and adjusted earnings of $0.12 per share, matching earnings expectations while exceeding revenue estimates.", "age_days": 15.5, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "neutral", "story_key": "365f94889e5a782076bde86dad626dd62463f35c192a6dd0e102e46080f3da46", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.marketbeat.com/instant-alerts/filing-tocqueville-asset-management-lp-takes-803-million-position-in-axogen-inc-axgn-2026-08-20", "source_name": "MarketBeat", "published_at": "2026-08-20T10:10:16", "source_names": ["MarketBeat"], "target_scope": "Takes $8.03 Million Position in AxoGen, Inc. $AXGN has acquired a new position in AxoGen, Inc. (NASDAQ:AXGN), purchasing 173,900 shares valued at approximately $8.03 million. Despite institutional investors owning over 80% of the company and a \"Moderate Buy\" consensus rating from analysts, AxoGen remains unprofitable, with insiders selling significant amounts of stock.", "tone_signals": ["Institutional or insider buying"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 11.6, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.014664, "influence_label": "None", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 53, "model_confidence": 0.526, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "20 Aug 2026 10:10", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.146}, {"url": "https://www.investing.com/news/company-news/axogen-stock-reaches-52week-high-at-500-usd-93CH-4865553", "tier": "direct", "title": "Axogen stock reaches 52-week high at 50.0 USD", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Axogen Inc. (AXGN) has reached a new 52-week high of $50.00, reflecting a 222.92% growth over the past year and strong market sentiment. Despite this achievement, InvestingPro analysis suggests the stock is overvalued. The company recently reported significant revenue growth of 23% in Q2 2026, surpassing analyst estimates, leading to increased price targets from H.C. Wainwright and Citizens.", "age_days": 17.4, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "neutral", "story_key": "a94190008307b6433c345b11bfbb62eac0cb87a9bce9179928c6094cf5af3aac", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.investing.com/news/company-news/axogen-stock-reaches-52week-high-at-500-usd-93CH-4865553", "source_name": "Investing.com", "published_at": "2026-08-18T13:39:50", "source_names": ["Investing.com"], "target_scope": "Axogen stock reaches 52-week high at 50.0 USD Axogen Inc. (AXGN) has reached a new 52-week high of $50.00, reflecting a 222.92% growth over the past year and strong market sentiment.", "tone_signals": ["Operating growth", "Negative valuation view"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 9.0, "sentiment_pct": 53, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.01651, "influence_label": "None", "provider_symbol": "", "relevance_score": 0.78, "archive_provider": "", "event_confidence": 53, "model_confidence": 0.594, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "18 Aug 2026 13:39", "direction_included": false, "sentiment_conflict": 0.27, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.0121}, {"url": "https://www.marketbeat.com/instant-alerts/filing-rice-hall-james-associates-llc-invests-341-million-in-axogen-inc-axgn-2026-08-18", "tier": "direct", "title": "Rice Hall James & Associates LLC Invests $3.41 Million in AxoGen, Inc. $AXGN", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Rice Hall James & Associates LLC acquired a new stake of 73,903 shares in AxoGen, Inc. ($AXGN) during the second quarter, valued at approximately $3.41 million. Institutional investors collectively own 80.29% of AxoGen, while insider activity shows recent sales totaling $4.48 million. Analysts maintain a \"Moderate Buy\" rating for AxoGen with an average target price of $51.00, following the company's Q2 earnings report which met EPS estimates and exceeded revenue expectations.", "age_days": 17.5, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "positive", "story_key": "5164032baf165da14d59c34637a2f2e3c820d307b401454ab20d7805961b20e2", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.marketbeat.com/instant-alerts/filing-rice-hall-james-associates-llc-invests-341-million-in-axogen-inc-axgn-2026-08-18", "source_name": "MarketBeat", "published_at": "2026-08-18T10:39:50", "source_names": ["MarketBeat"], "target_scope": "Rice Hall James & Associates LLC Invests $3.41 Million in AxoGen, Inc. $AXGN Rice Hall James & Associates LLC acquired a new stake of 73,903 shares in AxoGen, Inc. ($AXGN) during the second quarter, valued at approximately $3.41 million. Institutional investors collectively own 80.29% of AxoGen, while insider activity shows recent sales totaling $4.48 million. Analysts maintain a \"Moderate Buy\" rating for AxoGen with an average target price of $51.00, following the company's Q2 earnings report which met EPS estimates and exceeded revenue expectations.", "tone_signals": ["Beat expectations", "Institutional or insider buying"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 8.8, "sentiment_pct": 61, "evidence_basis": "archived_article", "evidence_share": 4.7, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.017922, "influence_label": "Medium", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 69, "model_confidence": 0.637, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 39, "published_display": "18 Aug 2026 10:39", "direction_included": true, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "4.7", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.3039}, {"url": "https://www.marketbeat.com/instant-alerts/filing-689833-shares-in-axogen-inc-axgn-bought-by-timessquare-capital-management-llc-2026-08-18", "tier": "direct", "title": "689,833 Shares in AxoGen, Inc. $AXGN Bought by TimesSquare Capital Management LLC", "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "summary": "TimesSquare Capital Management LLC has acquired 689,833 shares of AxoGen, Inc. (NASDAQ:AXGN) worth approximately $31.9 million, representing a 1.28% stake in the medical equipment provider. This move contributes to the 80.29% institutional ownership of the company. Despite recent insider selling, analysts maintain a \"Moderate Buy\" rating for AxoGen, with a consensus price target of $51.", "age_days": 17.6, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "positive", "story_key": "49b2d5b8ec1a6d5b928abac5533d68cf79f8552826f5ffaec332fdb95271777d", "event_type": "analyst", "tier_label": "Direct company coverage", "event_label": "Analyst action", "source_kind": "publisher", "source_link": "https://www.marketbeat.com/instant-alerts/filing-689833-shares-in-axogen-inc-axgn-bought-by-timessquare-capital-management-llc-2026-08-18", "source_name": "MarketBeat", "published_at": "2026-08-18T09:39:50", "source_names": ["MarketBeat"], "target_scope": "689,833 Shares in AxoGen, Inc. $AXGN Bought by TimesSquare Capital Management LLC TimesSquare Capital Management LLC has acquired 689,833 shares of AxoGen, Inc. (NASDAQ:AXGN) worth approximately $31.9 million, representing a 1.28% stake in the medical equipment provider. Despite recent insider selling, analysts maintain a \"Moderate Buy\" rating for AxoGen, with a consensus price target of $51.", "tone_signals": ["Institutional or insider buying"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 1.7, "sentiment_pct": 60, "evidence_basis": "archived_article", "evidence_share": 0.7, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.002746, "influence_label": "Low", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 61, "model_confidence": 0.634, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 33, "published_display": "18 Aug 2026 09:39", "direction_included": true, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0.7", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.2264}, {"url": "https://m.investing.com/news/insider-trading-news/axogen-director-amy-wendell-sells-646k-in-shares-93CH-4861808?ampMode=1", "tier": "direct", "title": "Axogen director Amy Wendell sells $646k in shares", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Axogen director Amy Wendell sold approximately $646,592 worth of common stock on August 11, 2026, following the exercise of employee stock options. This sale, conducted via a Rule 10b5-1 trading plan, occurred as the stock traded near its 52-week high, despite an InvestingPro analysis suggesting it might be overvalued. The company recently reported strong Q2 2026 revenue growth, exceeding Wall Street estimates, and received raised price targets from analysts.", "age_days": 20.3, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "negative", "story_key": "bc11b76b23d8f825a959376cb9f2c08043125cb697759232a89abfd6b1774185", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://m.investing.com/news/insider-trading-news/axogen-director-amy-wendell-sells-646k-in-shares-93CH-4861808?ampMode=1", "source_name": "Investing.com", "published_at": "2026-08-15T15:42:31", "source_names": ["Investing.com"], "target_scope": "Axogen director Amy Wendell sells $646k in shares Axogen director Amy Wendell sold approximately $646,592 worth of common stock on August 11, 2026, following the exercise of employee stock options.", "tone_signals": ["Institutional or insider selling", "Negative valuation view"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 6.0, "sentiment_pct": 42, "evidence_basis": "archived_article", "evidence_share": 3.6, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.013993, "influence_label": "Low", "provider_symbol": "", "relevance_score": 0.78, "archive_provider": "", "event_confidence": 53, "model_confidence": 0.668, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 35, "published_display": "15 Aug 2026 15:42", "direction_included": true, "sentiment_conflict": 0.373, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "3.6", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.011}, {"url": "https://www.stocktitan.net/sec-filings/AXGN/schedule-13g-a-axogen-inc-amended-passive-investment-disclosure-73b59a4d36b4.html", "tier": "direct", "title": "First Light Asset Management (AXGN) discloses 7.58% Axogen stake for Mathew Arens", "topics": ["Financial Markets", "Life Sciences"], "summary": "First Light Asset Management, LLC and Mathew P. Arens have filed an amended Schedule 13G disclosing their beneficial ownership in Axogen, Inc. First Light Asset Management may be deemed to beneficially own 3,746,380 shares (6.97% of the class), while Mathew P. Arens may be deemed to beneficially own 4,072,910 shares (7.58% of the class). Arens's ownership includes shares controlled through the Manager, direct holdings, and a joint account.", "age_days": 21.1, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "neutral", "story_key": "ebcb576c0da9af8dc42123009d59bbbe807713a51e3b504c0bcff227e04acea6", "event_type": "deals", "tier_label": "Direct company coverage", "event_label": "Deals and strategy", "source_kind": "publisher", "source_link": "https://www.stocktitan.net/sec-filings/AXGN/schedule-13g-a-axogen-inc-amended-passive-investment-disclosure-73b59a4d36b4.html", "source_name": "Stock Titan", "published_at": "2026-08-14T20:41:19", "source_names": ["Stock Titan"], "target_scope": "First Light Asset Management (AXGN) discloses 7.58% Axogen stake for Mathew Arens Arens have filed an amended Schedule 13G disclosing their beneficial ownership in Axogen, Inc.", "tone_signals": [], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 12.4, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.010703, "influence_label": "None", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 53, "model_confidence": 0.4, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "14 Aug 2026 20:41", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.1224}, {"url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5QTEpYRmtoYzFUbnF6WElMU1NoeUhwVGhNZkRQNWhOOFVuRGN4N1FoQ19kdml4SlNXNU53R01EUHNEZTRoQXp2bzFkSUczd05SZFd5b2NBRk1Sc2V6V3dWOW52LVN5WkJGWm8tYmJoeUdpRlFGRlEydG9VaU4?oc=5", "tier": "direct", "title": "Axogen (AXGN) Q2 2026 Earnings Call Transcript", "topics": [], "summary": "", "age_days": 22.0, "is_stale": false, "provider": "archive", "providers": ["archive"], "sentiment": "neutral", "story_key": "6869d72b06db85e5d04c007c9e87d13cf9b603d61f160bb959659c25d01b4854", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5QTEpYRmtoYzFUbnF6WElMU1NoeUhwVGhNZkRQNWhOOFVuRGN4N1FoQ19kdml4SlNXNU53R01EUHNEZTRoQXp2bzFkSUczd05SZFd5b2NBRk1Sc2V6V3dWOW52LVN5WkJGWm8tYmJoeUdpRlFGRlEydG9VaU4?oc=5", "source_name": "AOL.com", "published_at": "2026-08-13T22:13:47+00:00", "source_names": ["AOL.com"], "target_scope": "Axogen (AXGN) Q2 2026 Earnings Call Transcript", "tone_signals": [], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 4.7, "sentiment_pct": 50, "evidence_basis": "headline_only", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": true, "evidence_weight": 0.003883, "influence_label": "None", "provider_symbol": "", "relevance_score": 0.78, "archive_provider": "google_news", "event_confidence": 53, "model_confidence": 0.4, "provider_symbols": ["AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "13 Aug 2026 22:13", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN.ARCHIVE", "provider_directional_mass": null}, {"url": "https://www.marketbeat.com/instant-alerts/filing-axogen-inc-axgn-shares-sold-by-wasatch-advisors-lp-2026-08-12", "tier": "direct", "title": "AxoGen, Inc. $AXGN Shares Sold by Wasatch Advisors LP", "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "summary": "Wasatch Advisors LP has reduced its stake in AxoGen, Inc. by 30.2%, selling over 560,000 shares but still retaining 1.30 million shares valued at approximately $59.9 million. Despite this sale, institutional investors collectively own 80.29% of the company, and analyst sentiment remains positive with a \"Moderate Buy\" consensus rating. AxoGen recently reported quarterly revenue of $69.73 million and adjusted earnings of $0.12 per share, meeting EPS estimates and exceeding revenue expectations.", "age_days": 22.9, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "negative", "story_key": "7397a4b41f5a97f3909205dae20fbe9f9dd3ec1b672ded0cb9e5e955c3a69e73", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.marketbeat.com/instant-alerts/filing-axogen-inc-axgn-shares-sold-by-wasatch-advisors-lp-2026-08-12", "source_name": "MarketBeat", "published_at": "2026-08-13T02:11:02", "source_names": ["MarketBeat"], "target_scope": "AxoGen, Inc. $AXGN Shares Sold by Wasatch Advisors LP Wasatch Advisors LP has reduced its stake in AxoGen, Inc. AxoGen recently reported quarterly revenue of $69.73 million and adjusted earnings of $0.12 per share, meeting EPS estimates and exceeding revenue expectations.", "tone_signals": ["Institutional or insider selling"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 4.2, "sentiment_pct": 42, "evidence_basis": "archived_article", "evidence_share": 2.0, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.007552, "influence_label": "Low", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 69, "model_confidence": 0.607, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 34, "published_display": "13 Aug 2026 02:11", "direction_included": true, "sentiment_conflict": 0.244, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "2", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.2006}, {"url": "https://www.marketbeat.com/instant-alerts/axogen-nasdaqaxgn-director-sells-64655226-in-stock-2026-08-12", "tier": "direct", "title": "AxoGen (NASDAQ:AXGN) Director Sells $646,552.26 in Stock", "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "summary": "AxoGen Director Amy McBride Wendell sold 13,353 shares of AXGN stock for over $646,000, reducing her total holdings by 11.01%. This sale occurred under a pre-arranged Rule 10b5-1 plan, and comes as AxoGen shares traded up 2.5% to $49.67, near their 52-week high, following strong earnings that met EPS expectations and exceeded revenue estimates.", "age_days": 23.0, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "negative", "story_key": "f9fb7e5c9fc0d60ef262d06f1a102a1ab86750b3ca2938224a411ce1352d19d2", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.marketbeat.com/instant-alerts/axogen-nasdaqaxgn-director-sells-64655226-in-stock-2026-08-12", "source_name": "MarketBeat", "published_at": "2026-08-12T21:41:35", "source_names": ["MarketBeat"], "target_scope": "AxoGen (NASDAQ:AXGN) Director Sells $646,552.26 in Stock AxoGen Director Amy McBride Wendell sold 13,353 shares of AXGN stock for over $646,000, reducing her total holdings by 11.01%. This sale occurred under a pre-arranged Rule 10b5-1 plan, and comes as AxoGen shares traded up 2.5% to $49.67, near their 52-week high, following strong earnings that met EPS expectations and exceeded revenue estimates.", "tone_signals": ["Institutional or insider selling"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 4.1, "sentiment_pct": 42, "evidence_basis": "archived_article", "evidence_share": 1.9, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.007371, "influence_label": "Low", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 93, "model_confidence": 0.608, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 34, "published_display": "12 Aug 2026 21:41", "direction_included": true, "sentiment_conflict": 0.747, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "1.9", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.279}, {"url": "https://www.marketbeat.com/instant-alerts/axogen-nasdaqaxgn-evp-marc-began-sells-67500-shares-of-stock-2026-08-12", "tier": "direct", "title": "AxoGen (NASDAQ:AXGN) EVP Marc Began Sells 67,500 Shares of Stock", "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "summary": "AxoGen EVP Marc Began sold 67,500 shares of company stock for approximately $3.20 million, reducing his direct holdings by over 57%. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan. Despite the insider sale, AxoGen shares rose, nearing their 52-week high, and the company reported strong quarterly results that met earnings expectations and exceeded revenue estimates.", "age_days": 23.0, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "negative", "story_key": "3b2fa350318fb37dc60baa19838764cc302fff73d77fee93e99f33df161453ac", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.marketbeat.com/instant-alerts/axogen-nasdaqaxgn-evp-marc-began-sells-67500-shares-of-stock-2026-08-12", "source_name": "MarketBeat", "published_at": "2026-08-12T21:41:35", "source_names": ["MarketBeat"], "target_scope": "AxoGen (NASDAQ:AXGN) EVP Marc Began Sells 67,500 Shares of Stock AxoGen EVP Marc Began sold 67,500 shares of company stock for approximately $3.20 million, reducing his direct holdings by over 57%. Despite the insider sale, AxoGen shares rose, nearing their 52-week high, and the company reported strong quarterly results that met earnings expectations and exceeded revenue estimates.", "tone_signals": ["Institutional or insider selling"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 4.1, "sentiment_pct": 42, "evidence_basis": "archived_article", "evidence_share": 1.8, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.007116, "influence_label": "Low", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 69, "model_confidence": 0.587, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 34, "published_display": "12 Aug 2026 21:41", "direction_included": true, "sentiment_conflict": 0.9, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "1.8", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.21}, {"url": "https://www.marketscreener.com/news/axogen-insider-sold-shares-worth-3-195-788-according-to-a-recent-sec-filing-ce7859d8d18bfe26", "tier": "direct", "title": "Axogen Insider Sold Shares Worth $3,195,788, According to a Recent SEC Filing", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "An insider at Axogen (AXGN) sold shares valued at $3,195,788, as disclosed in a recent SEC filing. This transaction follows another reported insider sale of $646,592 on the same day. Axogen specializes in technologies for peripheral nerve regeneration and repair.", "age_days": 23.1, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "negative", "story_key": "25ec232b47818dfb4e07bf2cb7d0f301179314071c23ee0ef22a264cdf6f9f1f", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.marketscreener.com/news/axogen-insider-sold-shares-worth-3-195-788-according-to-a-recent-sec-filing-ce7859d8d18bfe26", "source_name": "www.marketscreener.com", "published_at": "2026-08-12T20:41:12", "source_names": ["www.marketscreener.com"], "target_scope": "Axogen Insider Sold Shares Worth $3,195,788, According to a Recent SEC Filing An insider at Axogen (AXGN) sold shares valued at $3,195,788, as disclosed in a recent SEC filing. Axogen specializes in technologies for peripheral nerve regeneration and repair.", "tone_signals": ["Institutional or insider selling"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 4.1, "sentiment_pct": 40, "evidence_basis": "archived_article", "evidence_share": 2.1, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.008062, "influence_label": "Medium", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 53, "model_confidence": 0.634, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 36, "published_display": "12 Aug 2026 20:41", "direction_included": true, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "2.1", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.4343}, {"url": "https://www.stocktitan.net/sec-filings/AXGN/144-axogen-inc-sec-filing-eaf13d04bf65.html", "tier": "direct", "title": "Axogen, Inc. SEC Filing (Aug 11, 2026)", "topics": ["Earnings", "Finance", "Life Sciences"], "summary": "This article reports on an SEC Form 144 filing by Axogen, Inc. (AXGN) on August 11, 2026, detailing a proposed sale of 13,353 common shares with an aggregate market value of $643,881.66 through Morgan Stanley Smith Barney LLC. The securities were acquired on the same date through the exercise of stock options. The filing indicates a neutral impact and sentiment according to AI analysis.", "age_days": 24.0, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "neutral", "story_key": "c26c9771b1b6d0f37036480a60c288f2d2cb107bcc41faaa82613dc249242eb7", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.stocktitan.net/sec-filings/AXGN/144-axogen-inc-sec-filing-eaf13d04bf65.html", "source_name": "Stock Titan", "published_at": "2026-08-11T22:41:35", "source_names": ["Stock Titan"], "target_scope": "Axogen, Inc. This article reports on an SEC Form 144 filing by Axogen, Inc. (AXGN) on August 11, 2026, detailing a proposed sale of 13,353 common shares with an aggregate market value of $643,881.66 through Morgan Stanley Smith Barney LLC.", "tone_signals": [], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 3.6, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 2, "durable_archive": false, "evidence_weight": 0.003443, "influence_label": "None", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 53, "model_confidence": 0.4, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "11 Aug 2026 22:41", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.0221}, {"url": "https://simplywall.st/stocks/us/healthcare/nasdaq-axgn/axogen/news/axogen-axgn-is-up-54-after-raising-2026-revenue-outlook-desp/amp", "tier": "direct", "title": "Axogen (AXGN) Is Up 5.4% After Raising 2026 Revenue Outlook Despite Ongoing Losses \u2013 Has The Bull Case Changed?", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Axogen (AXGN) reported higher Q2 2026 revenue of US$69.73 million but increased net losses of US$1.52 million. Despite ongoing losses, the company raised its full-year 2026 revenue outlook to at least US$279 million, leading to a 5.4% stock increase. This updated guidance reinforces the company's growth story in nerve repair solutions, though investors should consider risks like reliance on a single product and regulatory pressures.", "age_days": 24.3, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "negative", "story_key": "19b246a63d92585ebbe901deb213798b4e98770d75c27218a3b6c8a5c8ab9a35", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://simplywall.st/stocks/us/healthcare/nasdaq-axgn/axogen/news/axogen-axgn-is-up-54-after-raising-2026-revenue-outlook-desp/amp", "source_name": "Simply Wall Street", "published_at": "2026-08-11T16:39:40", "source_names": ["Simply Wall Street"], "target_scope": "Axogen (AXGN) Is Up 5.4% After Raising 2026 Revenue Outlook Despite Ongoing Losses \u2013 Has The Bull Case Changed? Axogen (AXGN) reported higher Q2 2026 revenue of US$69.73 million but increased net losses of US$1.52 million.", "tone_signals": ["Positive financial language"], "company_focus": 0.78, "cross_listing": false, "entity_mapped": true, "freshness_pct": 3.5, "sentiment_pct": 42, "evidence_basis": "archived_article", "evidence_share": 1.1, "score_included": true, "duplicate_count": 2, "durable_archive": false, "evidence_weight": 0.004167, "influence_label": "Low", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 61, "model_confidence": 0.522, "provider_symbols": ["AXGN", "AXGN.ARCHIVE", "BAX", "BDX"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 78, "evidence_strength": 30, "published_display": "11 Aug 2026 16:39", "direction_included": true, "sentiment_conflict": 0.981, "company_focus_label": "Shared story", "source_link_is_lookup": false, "evidence_share_display": "1.1", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.2566}, {"url": "https://ca.investing.com/news/stock-market-news/axogen-stock-hits-52week-high-at-4709-usd-93CH-4789947", "tier": "direct", "title": "Axogen stock hits 52-week high at 47.09 USD By Investing.com", "topics": ["Earnings", "Financial Markets", "Life Sciences"], "summary": "Axogen Inc. (AXGN) stock reached a new 52-week high of $47.09, trading at $47.11 with a market capitalization of $2.52 billion, representing a 231.91% surge over the past year. InvestingPro analysis indicates the stock is currently overvalued, yet net income is projected to grow, with analysts forecasting profitability. Recent Q2 2026 financial results showed revenue of $69.7 million, exceeding estimates, and analysts have raised price targets for the company.", "age_days": 25.4, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "neutral", "story_key": "76f7071c9e52d6cfb65aa303842c0f2ce0ff356b46cdc9c6c7295c626246c000", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://ca.investing.com/news/stock-market-news/axogen-stock-hits-52week-high-at-4709-usd-93CH-4789947", "source_name": "Investing.com Canada", "published_at": "2026-08-10T14:11:49", "source_names": ["Investing.com Canada"], "target_scope": "Axogen stock hits 52-week high at 47.09 USD By Investing.com Axogen Inc. (AXGN) stock reached a new 52-week high of $47.09, trading at $47.11 with a market capitalization of $2.52 billion, representing a 231.91% surge over the past year.", "tone_signals": ["Negative valuation view"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 3.0, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 2, "durable_archive": false, "evidence_weight": 0.004953, "influence_label": "None", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 53, "model_confidence": 0.508, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "10 Aug 2026 14:11", "direction_included": false, "sentiment_conflict": 0.195, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.5197}, {"url": "https://news.google.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?oc=5", "tier": "direct", "title": "Is Axogen (AXGN) Still Below Fair Value As Strong Q2 Results Lift Guidance?", "topics": [], "summary": "", "age_days": 25.7, "is_stale": false, "provider": "archive", "providers": ["archive"], "sentiment": "positive", "story_key": "0f19088b9dbdc940e0543b8ee3f7a15b7c6390ddb622c6c6ebcac60de3497678", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-08-10T07:00:00+00:00", "source_names": ["simplywall.st"], "target_scope": "Is Axogen (AXGN) Still Below Fair Value As Strong Q2 Results Lift Guidance?", "tone_signals": ["Guidance raised"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 2.9, "sentiment_pct": 79, "evidence_basis": "headline_only", "evidence_share": 1.8, "score_included": true, "duplicate_count": 1, "durable_archive": true, "evidence_weight": 0.006761, "influence_label": "Medium", "provider_symbol": "", "relevance_score": 0.78, "archive_provider": "google_news", "event_confidence": 53, "model_confidence": 0.619, "provider_symbols": ["AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 55, "published_display": "10 Aug 2026 07:00", "direction_included": true, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "1.8", "target_provider_symbol": "AXGN.ARCHIVE", "provider_directional_mass": null}, {"url": "https://www.tradingkey.com/markets/stocks/axgn/news", "tier": "direct", "title": "AxoGen Inc (AXGN) Stock News Today", "topics": ["Financial Markets", "Life Sciences"], "summary": "This article provides an overview of AxoGen Inc (AXGN) stock, including its current price, market capitalization, and a note that more", "age_days": 27.3, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "neutral", "story_key": "ebc7c6ff3cbccc981840d378c48826e058c426ffa2ce73b24ab1aa21f5ccef97", "event_type": "general", "tier_label": "Direct company coverage", "event_label": "Market update", "source_kind": "publisher", "source_link": "https://www.tradingkey.com/markets/stocks/axgn/news", "source_name": "TradingKey", "published_at": "2026-08-08T16:11:49", "source_names": ["TradingKey"], "target_scope": "AxoGen Inc (AXGN) Stock News Today This article provides an overview of AxoGen Inc (AXGN) stock, including its current price, market capitalization, and a note that more", "tone_signals": [], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 0.0, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 5e-06, "influence_label": "None", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 35, "model_confidence": 0.4, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "08 Aug 2026 16:11", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.0921}, {"url": "https://www.theglobeandmail.com/investing/markets/stocks/AXGN-Q/pressreleases/3730971/axogen-axgn-q2-2026-earnings-call-transcript", "tier": "direct", "title": "Axogen (AXGN) Q2 2026 Earnings Call Transcript", "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "summary": "Axogen (AXGN) reported strong Q2 2026 financial results with revenue up 23.1% year-over-year, driven primarily by significant growth in its Breast segment. The company raised its full-year revenue guidance to at least $279 million, reflecting confidence in its commercial execution and sales force productivity, though it revised its gross margin guidance to at least 73% due to a shift in product mix towards higher-cost breast procedures. Axogen also highlighted strategic investments in imaging technology and ongoing clinical development in prostate repair, emphasizing its commitment to expanding peripheral nerve care.", "age_days": 28.0, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "positive", "story_key": "6869d72b06db85e5d04c007c9e87d13cf9b603d61f160bb959659c25d01b4854", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.theglobeandmail.com/investing/markets/stocks/AXGN-Q/pressreleases/3730971/axogen-axgn-q2-2026-earnings-call-transcript", "source_name": "The Globe and Mail", "published_at": "2026-08-07T23:40:13", "source_names": ["The Globe and Mail"], "target_scope": "Axogen (AXGN) Q2 2026 Earnings Call Transcript Axogen (AXGN) reported strong Q2 2026 financial results with revenue up 23.1% year-over-year, driven primarily by significant growth in its Breast segment. Axogen also highlighted strategic investments in imaging technology and ongoing clinical development in prostate repair, emphasizing its commitment to expanding peripheral nerve care.", "tone_signals": ["Guidance raised"], "company_focus": 0.78, "cross_listing": false, "entity_mapped": true, "freshness_pct": 2.1, "sentiment_pct": 60, "evidence_basis": "archived_article", "evidence_share": 0.7, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.002796, "influence_label": "Low", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 69, "model_confidence": 0.56, "provider_symbols": ["AXGN", "AXGN.ARCHIVE", "ELV", "HUM"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 78, "evidence_strength": 32, "published_display": "07 Aug 2026 23:40", "direction_included": true, "sentiment_conflict": 0.0, "company_focus_label": "Shared story", "source_link_is_lookup": false, "evidence_share_display": "0.7", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.5299}, {"url": "https://www.stocktitan.net/sec-filings/AXGN/144-axogen-inc-sec-filing-dbcdf13fb5f0.html", "tier": "direct", "title": "Axogen, Inc. SEC Filing (Aug 7, 2026)", "topics": ["Earnings", "Finance", "Financial Markets", "Life Sciences"], "summary": "This article reports on an SEC Form 144 filing by Axogen, Inc. (AXGN) on August 7, 2026. The filing indicates a proposed sale of 14,150 shares with an aggregate market value of $627,552.50, acquired through Restricted Stock Units on June 19, 2026. The filing also notes that 53,761,513 shares are outstanding and the sale is anticipated to occur on NASDAQ.", "age_days": 28.1, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "neutral", "story_key": "8424dfea9de72045c363cf30111e9091b1bc057f45b2527284f380185e03e37f", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.stocktitan.net/sec-filings/AXGN/144-axogen-inc-sec-filing-dbcdf13fb5f0.html", "source_name": "Stock Titan", "published_at": "2026-08-07T20:11:08", "source_names": ["Stock Titan"], "target_scope": "Axogen, Inc. This article reports on an SEC Form 144 filing by Axogen, Inc. (AXGN) on August 7, 2026.", "tone_signals": [], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 2.0, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.001949, "influence_label": "None", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 53, "model_confidence": 0.4, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "07 Aug 2026 20:11", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.0165}, {"url": "https://www.reveliolabs.com/companies/axogen/employees", "tier": "direct", "title": "AxoGen Number of Employees 2026 | Employee Count & Headcount Data", "topics": ["Earnings", "Life Sciences"], "summary": "AxoGen (NASDAQ: AXGN) has 652 employees globally as of March 2026, marking a 36.7% growth since 2023. The company is actively hiring with 57 job postings in 2026, and its workforce is primarily concentrated in North America. Despite growth, overall employee sentiment is negative and declining, and the average salary is $112,705.", "age_days": 28.3, "is_stale": false, "provider": "alphavantage", "providers": ["alphavantage"], "sentiment": "neutral", "story_key": "1d27a552463f70398e7081da3f2674b08284f81e05194757c1d40b82a1f2e3ac", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://www.reveliolabs.com/companies/axogen/employees", "source_name": "Revelio Labs", "published_at": "2026-08-07T15:42:35", "source_names": ["Revelio Labs"], "target_scope": "AxoGen Number of Employees 2026 | Employee Count & Headcount Data AxoGen (NASDAQ: AXGN) has 652 employees globally as of March 2026, marking a 36.7% growth since 2023.", "tone_signals": ["Negative financial language"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 2.0, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 1, "durable_archive": false, "evidence_weight": 0.002141, "influence_label": "None", "provider_symbol": "", "relevance_score": 1.0, "archive_provider": "", "event_confidence": 53, "model_confidence": 0.451, "provider_symbols": ["AXGN", "AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 0, "published_display": "07 Aug 2026 15:42", "direction_included": false, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "0", "target_provider_symbol": "AXGN", "provider_directional_mass": 0.1286}, {"url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNeTJoYTNzZzBrZ1BEU2FTWDlpZlN3M0c2ekdIazFCU2Rtc2JWbDRkNm52OTNGZEI4Mk9oVDFMZzMwWFhCX0d0RmFXaktKam5DSWFNOWtpU3pUX192bEIwcXM1MlFLcElPN1dlWFhmQUtnYUxYS0tBaFAxdWxGZjBvaFZTNDFOUS12WlBfakp0TXNVSFN4WE95Zmp1aXIyRjFUQmFyVzE3ZUhmQkExd2lF?oc=5", "tier": "direct", "title": "AXGN Q2 2026 Earnings: EPS of $0.12 Edges Below Consensus, Shares Dip 1.92% - Earnings Quality Analysis", "topics": [], "summary": "", "age_days": 28.7, "is_stale": false, "provider": "archive", "providers": ["archive"], "sentiment": "negative", "story_key": "63f4936d3394becc81113c37a133a92c2395eb26774482735b49642901feeb8d", "event_type": "earnings", "tier_label": "Direct company coverage", "event_label": "Earnings", "source_kind": "publisher", "source_link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNeTJoYTNzZzBrZ1BEU2FTWDlpZlN3M0c2ekdIazFCU2Rtc2JWbDRkNm52OTNGZEI4Mk9oVDFMZzMwWFhCX0d0RmFXaktKam5DSWFNOWtpU3pUX192bEIwcXM1MlFLcElPN1dlWFhmQUtnYUxYS0tBaFAxdWxGZjBvaFZTNDFOUS12WlBfakp0TXNVSFN4WE95Zmp1aXIyRjFUQmFyVzE3ZUhmQkExd2lF?oc=5", "source_name": "vinanet.vn", "published_at": "2026-08-07T07:00:00+00:00", "source_names": ["vinanet.vn"], "target_scope": "AXGN Q2 2026 Earnings: EPS of $0.12 Edges Below Consensus, Shares Dip 1.92% - Earnings Quality Analysis", "tone_signals": ["Missed expectations"], "company_focus": 1.0, "cross_listing": false, "entity_mapped": true, "freshness_pct": 1.9, "sentiment_pct": 25, "evidence_basis": "headline_only", "evidence_share": 1.0, "score_included": true, "duplicate_count": 1, "durable_archive": true, "evidence_weight": 0.004021, "influence_label": "Medium", "provider_symbol": "", "relevance_score": 0.78, "archive_provider": "google_news", "event_confidence": 61, "model_confidence": 0.59, "provider_symbols": ["AXGN.ARCHIVE"], "sentiment_origin": "stored_reclassified", "company_focus_pct": 100, "evidence_strength": 51, "published_display": "07 Aug 2026 07:00", "direction_included": true, "sentiment_conflict": 0.0, "company_focus_label": "Main company", "source_link_is_lookup": false, "evidence_share_display": "1", "target_provider_symbol": "AXGN.ARCHIVE", "provider_directional_mass": null}], "industry": [], "sector": []}, "detail_intelligence": {"headline": "Early balanced news score", "summary": "36 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.", "status": "provisional", "metrics": [{"label": "News score", "value": 55, "display": "55", "tone": "neutral", "note": "Early balanced news score"}, {"label": "Confidence", "value": 26, "display": "26", "tone": "negative", "note": "thin evidence"}, {"label": "Company news", "value": 100, "display": "100%", "tone": "positive", "note": "36 company stories"}, {"label": "Story agreement", "value": 79, "display": "79", "tone": "positive", "note": "21/100 difference"}], "confidence_drivers": [{"label": "Amount of evidence", "value": 8, "note": "0.385 after freshness weighting"}, {"label": "Source breadth", "value": 100, "note": "10 independent publishers"}, {"label": "Company relevance", "value": 100, "note": "share tied directly to this company"}, {"label": "Freshness", "value": 10, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 79, "note": "how closely stories agree"}, {"label": "Publisher mix", "value": 74, "note": "less reliance on one publisher"}], "freshness": 10, "source_independence": 74, "timeline": [{"date": "2026-08-08", "label": "08 Aug", "count": 1, "score": 50, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 13.0, "volume_y": 253.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 0, "score": null, "tone": "neutral", "x": 73.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 2, "score": 67, "tone": "positive", "x": 105.2, "y": 104.1, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 2, "score": 46, "tone": "neutral", "x": 136.8, "y": 142.3, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-08-12", "label": "12 Aug", "count": 3, "score": 41, "tone": "negative", "x": 168.3, "y": 151.4, "volume_height": 39.0, "volume_y": 227.0}, {"date": "2026-08-13", "label": "13 Aug", "count": 2, "score": 45, "tone": "neutral", "x": 199.9, "y": 144.1, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-08-14", "label": "14 Aug", "count": 1, "score": 50, "tone": "neutral", "x": 231.5, "y": 135.0, "volume_height": 13.0, "volume_y": 253.0}, {"date": "2026-08-15", "label": "15 Aug", "count": 1, "score": 42, "tone": "negative", "x": 263.1, "y": 149.6, "volume_height": 13.0, "volume_y": 253.0}, {"date": "2026-08-16", "label": "16 Aug", "count": 0, "score": null, "tone": "neutral", "x": 294.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-17", "label": "17 Aug", "count": 0, "score": null, "tone": "neutral", "x": 326.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-18", "label": "18 Aug", "count": 3, "score": 57, "tone": "neutral", "x": 357.9, "y": 122.3, "volume_height": 39.0, "volume_y": 227.0}, {"date": "2026-08-19", "label": "19 Aug", "count": 0, "score": null, "tone": "neutral", "x": 389.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-20", "label": "20 Aug", "count": 4, "score": 50, "tone": "neutral", "x": 421.0, "y": 135.0, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-21", "label": "21 Aug", "count": 3, "score": 60, "tone": "positive", "x": 452.6, "y": 116.8, "volume_height": 39.0, "volume_y": 227.0}, {"date": "2026-08-22", "label": "22 Aug", "count": 3, "score": 79, "tone": "positive", "x": 484.2, "y": 82.2, "volume_height": 39.0, "volume_y": 227.0}, {"date": "2026-08-23", "label": "23 Aug", "count": 3, "score": 32, "tone": "negative", "x": 515.8, "y": 167.8, "volume_height": 39.0, "volume_y": 227.0}, {"date": "2026-08-24", "label": "24 Aug", "count": 0, "score": null, "tone": "neutral", "x": 547.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-25", "label": "25 Aug", "count": 1, "score": 50, "tone": "neutral", "x": 579.0, "y": 135.0, "volume_height": 13.0, "volume_y": 253.0}, {"date": "2026-08-26", "label": "26 Aug", "count": 1, "score": 84, "tone": "positive", "x": 610.6, "y": 73.1, "volume_height": 13.0, "volume_y": 253.0}, {"date": "2026-08-27", "label": "27 Aug", "count": 1, "score": 54, "tone": "neutral", "x": 642.1, "y": 127.7, "volume_height": 13.0, "volume_y": 253.0}, {"date": "2026-08-28", "label": "28 Aug", "count": 0, "score": null, "tone": "neutral", "x": 673.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-29", "label": "29 Aug", "count": 0, "score": null, "tone": "neutral", "x": 705.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-30", "label": "30 Aug", "count": 0, "score": null, "tone": "neutral", "x": 736.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-31", "label": "31 Aug", "count": 0, "score": null, "tone": "neutral", "x": 768.5, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-01", "label": "01 Sep", "count": 1, "score": 50, "tone": "neutral", "x": 800.1, "y": 135.0, "volume_height": 13.0, "volume_y": 253.0}, {"date": "2026-09-02", "label": "02 Sep", "count": 0, "score": null, "tone": "neutral", "x": 831.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-03", "label": "03 Sep", "count": 0, "score": null, "tone": "neutral", "x": 863.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-04", "label": "04 Sep", "count": 0, "score": null, "tone": "neutral", "x": 894.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-05", "label": "05 Sep", "count": 0, "score": null, "tone": "neutral", "x": 926.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-09-06", "label": "06 Sep", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "42.0,135.0 105.2,104.1 136.8,142.3 168.3,151.4 199.9,144.1 231.5,135.0 263.1,149.6 357.9,122.3 421.0,135.0 452.6,116.8 484.2,82.2 515.8,167.8 579.0,135.0 610.6,73.1 642.1,127.7 800.1,135.0", "timeline_has_signal": true, "timeline_start": "08 Aug", "timeline_mid": "23 Aug", "timeline_end": "06 Sep", "momentum": {"label": "Cooling", "tone": "neutral", "recent_score": null, "prior_score": 50, "delta": null, "recent_count": 0, "prior_count": 1, "volume_delta": -1, "reliable": false, "reliability_note": "Thin comparison; direction is not yet confirmed"}, "early_change": {"label": "No new story in 24 hours", "tone": "neutral", "latest_score": null, "baseline_score": 50, "delta": null, "latest_count": 0, "baseline_count": 1, "confirmed": false, "note": "A comparison needs current and earlier-week company news"}, "freshness_buckets": [{"label": "Last 24 hours", "count": 0, "share": 0}, {"label": "1 to 3 days", "count": 0, "share": 0}, {"label": "4 to 7 days", "count": 1, "share": 3}, {"label": "8 to 14 days", "count": 6, "share": 17}, {"label": "15 to 21 days", "count": 13, "share": 36}, {"label": "22 to 30 days", "count": 15, "share": 42}], "source_profile": [{"label": "MarketBeat", "count": 7, "share": 19, "score": 56, "tone": "neutral"}, {"label": "TradingView", "count": 5, "share": 14, "score": 50, "tone": "neutral"}, {"label": "Investing.com", "count": 4, "share": 11, "score": 72, "tone": "positive"}, {"label": "Stock Titan", "count": 3, "share": 8, "score": 50, "tone": "neutral"}, {"label": "vinanet.vn", "count": 2, "share": 6, "score": 25, "tone": "negative"}, {"label": "GuruFocus", "count": 2, "share": 6, "score": 50, "tone": "neutral"}, {"label": "StocksToTrade", "count": 1, "share": 3, "score": 80, "tone": "positive"}], "event_profile": [{"label": "Earnings", "count": 27, "share": 75, "score": 62, "tone": "positive"}, {"label": "Market update", "count": 5, "share": 14, "score": 50, "tone": "neutral"}, {"label": "Analyst action", "count": 3, "share": 8, "score": 78, "tone": "positive"}, {"label": "Deals and strategy", "count": 1, "share": 3, "score": 50, "tone": "neutral"}], "topics": [{"label": "Life Sciences", "count": 28, "share": 78}, {"label": "Financial Markets", "count": 25, "share": 69}, {"label": "Earnings", "count": 24, "share": 67}, {"label": "Finance", "count": 10, "share": 28}], "supporting": [{"label": "Direct evidence", "text": "36 current stories are mapped specifically to AXGN."}, {"label": "Source breadth", "text": "The score uses 10 publishers rather than depending on one outlet."}], "tempering": [{"label": "Too little evidence", "text": "The stories agree, but freshness-weighted evidence is only 0.385."}, {"label": "Confidence", "text": "Confidence is 26/100, below the threshold for a firm score."}], "supporting_heading": "What supports the score", "tempering_heading": "What limits the score", "latest_observation": {"url": "https://www.manilatimes.net/2026/09/01/tmt-newswire/globenewswire/axogen-inc-to-participate-in-the-24th-annual-morgan-stanley-global-healthcare-conference/2415867", "tier": "direct", "title": "Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference", "topics": ["Finance", "Life Sciences"], "summary": "Axogen, Inc. (NASDAQ: AXGN) announced its participation in the 24th Annual Morgan Stanley Global Healthcare Conference. Management will be available for one-on-one investor meetings on Tuesday, September 15, 2026. Axogen specializes in developing and marketing surgical solutions for peripheral nerve function restoration.", "age_days": 3.5, "is_stale": false, "sentiment": "neutral", "event_type": "general", "tier_label": "Direct company coverage", "event_label": "Market update", "source_kind": "publisher", "source_link": "https://www.manilatimes.net/2026/09/01/tmt-newswire/globenewswire/axogen-inc-to-participate-in-the-24th-annual-morgan-stanley-global-healthcare-conference/2415867", "source_name": "The Manila Times", "published_at": "2026-09-01T11:01:02", "tone_signals": [], "company_focus": 0.78, "freshness_pct": 29.8, "sentiment_pct": 50, "evidence_basis": "archived_article", "evidence_share": 0.0, "score_included": true, "duplicate_count": 2, "evidence_weight": 0.014253, "influence_label": "None", "event_confidence": 35, "company_focus_pct": 78, "evidence_strength": 0, "published_display": "01 Sep 2026 11:01", "direction_included": false, "company_focus_label": "Shared story", "source_link_is_lookup": false, "evidence_share_display": "0"}, "article_count": 36, "updated_at": "2026-09-04T22:52:07.390559+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 193.0, "label": "13 Mar 2026", "close": 32.34, "index": 100.0}, {"x": 78.4, "y": 204.2, "label": "20 Mar 2026", "close": 30.78, "index": 95.2}, {"x": 114.9, "y": 200.6, "label": "27 Mar 2026", "close": 31.28, "index": 96.7}, {"x": 151.3, "y": 177.9, "label": "03 Apr 2026", "close": 34.44, "index": 106.5}, {"x": 187.7, "y": 195.7, "label": "10 Apr 2026", "close": 31.96, "index": 98.8}, {"x": 224.2, "y": 148.8, "label": "17 Apr 2026", "close": 38.5, "index": 119.0}, {"x": 260.6, "y": 143.4, "label": "24 Apr 2026", "close": 39.25, "index": 121.4}, {"x": 297.0, "y": 114.5, "label": "01 May 2026", "close": 43.28, "index": 133.8}, {"x": 333.5, "y": 123.3, "label": "08 May 2026", "close": 42.06, "index": 130.1}, {"x": 369.9, "y": 131.0, "label": "15 May 2026", "close": 40.99, "index": 126.7}, {"x": 406.3, "y": 131.6, "label": "22 May 2026", "close": 40.9, "index": 126.5}, {"x": 442.8, "y": 141.8, "label": "29 May 2026", "close": 39.48, "index": 122.1}, {"x": 479.2, "y": 118.0, "label": "05 Jun 2026", "close": 42.8, "index": 132.3}, {"x": 515.6, "y": 116.6, "label": "12 Jun 2026", "close": 43.0, "index": 133.0}, {"x": 552.0, "y": 103.4, "label": "19 Jun 2026", "close": 44.84, "index": 138.7}, {"x": 588.5, "y": 102.7, "label": "26 Jun 2026", "close": 44.93, "index": 138.9}, {"x": 624.9, "y": 95.8, "label": "03 Jul 2026", "close": 45.89, "index": 141.9}, {"x": 661.3, "y": 133.9, "label": "10 Jul 2026", "close": 40.58, "index": 125.5}, {"x": 697.8, "y": 139.1, "label": "17 Jul 2026", "close": 39.85, "index": 123.2}, {"x": 734.2, "y": 141.7, "label": "24 Jul 2026", "close": 39.49, "index": 122.1}, {"x": 770.6, "y": 122.2, "label": "31 Jul 2026", "close": 42.21, "index": 130.5}, {"x": 807.1, "y": 92.0, "label": "07 Aug 2026", "close": 46.43, "index": 143.6}, {"x": 843.5, "y": 75.5, "label": "14 Aug 2026", "close": 48.73, "index": 150.7}, {"x": 879.9, "y": 63.5, "label": "21 Aug 2026", "close": 50.4, "index": 155.8}, {"x": 916.4, "y": 55.8, "label": "28 Aug 2026", "close": 51.47, "index": 159.2}, {"x": 952.8, "y": 78.7, "label": "04 Sep 2026", "close": 48.28, "index": 149.3}], "sentiment_points": [{"at": "2026-06-26T23:59:59.999Z", "date": "2026-06-26", "label": "26 Jun 2026", "score": 50, "tone": "neutral", "raw_score": 66, "confidence": 17, "stories": 4, "close": 44.93, "price_change": 0.2, "x": 593.7, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-07-03T23:59:59.999Z", "date": "2026-07-03", "label": "03 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 66, "confidence": 14, "stories": 8, "close": 45.89, "price_change": 2.1, "x": 630.1, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-07-10T23:59:59.999Z", "date": "2026-07-10", "label": "10 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 57, "confidence": 17, "stories": 10, "close": 40.58, "price_change": -11.6, "x": 666.5, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-07-17T23:59:59.999Z", "date": "2026-07-17", "label": "17 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 57, "confidence": 14, "stories": 15, "close": 39.85, "price_change": -1.8, "x": 703.0, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-07-24T23:59:59.999Z", "date": "2026-07-24", "label": "24 Jul 2026", "score": 46, "tone": "neutral", "raw_score": 40, "confidence": 35, "stories": 17, "close": 39.49, "price_change": -0.9, "x": 739.4, "y": 137.4, "show_label": true, "label_y": 127.4}, {"at": "2026-07-31T23:59:59.999Z", "date": "2026-07-31", "label": "31 Jul 2026", "score": 57, "tone": "neutral", "raw_score": 60, "confidence": 48, "stories": 41, "close": 42.21, "price_change": 6.9, "x": 775.8, "y": 117.1, "show_label": false, "label_y": 107.1}, {"at": "2026-08-07T23:59:59.999Z", "date": "2026-08-07", "label": "07 Aug 2026", "score": 52, "tone": "neutral", "raw_score": 53, "confidence": 38, "stories": 49, "close": 46.43, "price_change": 10.0, "x": 812.3, "y": 126.3, "show_label": true, "label_y": 116.3}, {"at": "2026-08-14T23:59:59.999Z", "date": "2026-08-14", "label": "14 Aug 2026", "score": 50, "tone": "neutral", "raw_score": 51, "confidence": 37, "stories": 56, "close": 48.73, "price_change": 5.0, "x": 848.7, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-08-21T23:59:59.999Z", "date": "2026-08-21", "label": "21 Aug 2026", "score": 52, "tone": "neutral", "raw_score": 55, "confidence": 34, "stories": 62, "close": 50.4, "price_change": 3.4, "x": 885.1, "y": 126.3, "show_label": true, "label_y": 116.3}, {"at": "2026-08-28T23:59:59.999Z", "date": "2026-08-28", "label": "28 Aug 2026", "score": 58, "tone": "positive", "raw_score": 67, "confidence": 36, "stories": 45, "close": 51.47, "price_change": 2.1, "x": 921.6, "y": 115.3, "show_label": false, "label_y": 105.3}, {"at": "2026-09-04T23:59:59.999Z", "date": "2026-09-04", "label": "04 Sep 2026", "score": 54, "tone": "neutral", "raw_score": 66, "confidence": 24, "stories": 36, "close": 48.28, "price_change": -6.2, "x": 958.0, "y": 122.6, "show_label": true, "label_y": 112.6}], "price_path": "42.0,193.0 78.4,204.2 114.9,200.6 151.3,177.9 187.7,195.7 224.2,148.8 260.6,143.4 297.0,114.5 333.5,123.3 369.9,131.0 406.3,131.6 442.8,141.8 479.2,118.0 515.6,116.6 552.0,103.4 588.5,102.7 624.9,95.8 661.3,133.9 697.8,139.1 734.2,141.7 770.6,122.2 807.1,92.0 843.5,75.5 879.9,63.5 916.4,55.8 952.8,78.7", "sentiment_path": "593.7,130.0 630.1,130.0 666.5,130.0 703.0,130.0 739.4,137.4 775.8,117.1 812.3,126.3 848.7,130.0 885.1,126.3 921.6,115.3 958.0,122.6", "score_version": "evidence-v10", "price_change": 49.3, "sentiment_change": 4, "recent_pairs": [{"at": "2026-09-04T23:59:59.999Z", "date": "2026-09-04", "label": "04 Sep 2026", "score": 54, "tone": "neutral", "raw_score": 66, "confidence": 24, "stories": 36, "close": 48.28, "price_change": -6.2, "x": 958.0, "y": 122.6, "show_label": true, "label_y": 112.6}, {"at": "2026-08-28T23:59:59.999Z", "date": "2026-08-28", "label": "28 Aug 2026", "score": 58, "tone": "positive", "raw_score": 67, "confidence": 36, "stories": 45, "close": 51.47, "price_change": 2.1, "x": 921.6, "y": 115.3, "show_label": false, "label_y": 105.3}, {"at": "2026-08-21T23:59:59.999Z", "date": "2026-08-21", "label": "21 Aug 2026", "score": 52, "tone": "neutral", "raw_score": 55, "confidence": 34, "stories": 62, "close": 50.4, "price_change": 3.4, "x": 885.1, "y": 126.3, "show_label": true, "label_y": 116.3}, {"at": "2026-08-14T23:59:59.999Z", "date": "2026-08-14", "label": "14 Aug 2026", "score": 50, "tone": "neutral", "raw_score": 51, "confidence": 37, "stories": 56, "close": 48.73, "price_change": 5.0, "x": 848.7, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-08-07T23:59:59.999Z", "date": "2026-08-07", "label": "07 Aug 2026", "score": 52, "tone": "neutral", "raw_score": 53, "confidence": 38, "stories": 49, "close": 46.43, "price_change": 10.0, "x": 812.3, "y": 126.3, "show_label": true, "label_y": 116.3}, {"at": "2026-07-31T23:59:59.999Z", "date": "2026-07-31", "label": "31 Jul 2026", "score": 57, "tone": "neutral", "raw_score": 60, "confidence": 48, "stories": 41, "close": 42.21, "price_change": 6.9, "x": 775.8, "y": 117.1, "show_label": false, "label_y": 107.1}, {"at": "2026-07-24T23:59:59.999Z", "date": "2026-07-24", "label": "24 Jul 2026", "score": 46, "tone": "neutral", "raw_score": 40, "confidence": 35, "stories": 17, "close": 39.49, "price_change": -0.9, "x": 739.4, "y": 137.4, "show_label": true, "label_y": 127.4}, {"at": "2026-07-17T23:59:59.999Z", "date": "2026-07-17", "label": "17 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 57, "confidence": 14, "stories": 15, "close": 39.85, "price_change": -1.8, "x": 703.0, "y": 130.0, "show_label": false, "label_y": 120.0}], "reconstructed": true, "latest_close": 48.28, "price_observations": 26, "sentiment_observations": 11, "sentiment_start_label": "26 Jun 2026", "sentiment_end_label": "04 Sep 2026", "sentiment_history_limited": false, "price_axis_high": 166.8, "price_axis_mid": 127.2, "price_axis_low": 87.5, "start_label": "13 Mar", "mid_label": "09 Jun", "end_label": "04 Sep", "live_score_version": "evidence-v10", "comparable_to_live": true}, "sentiment_history": [{"label": "20 Jun 23:59", "short_label": "20 Jun", "collected_at": "2026-06-20T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "neutral", "height": 4, "articles": 1, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v10", "reconstructed": true}, {"label": "22 Jun 23:59", "short_label": "22 Jun", "collected_at": "2026-06-22T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 1, "score_change_display": "+1", "confidence_change": 28, "article_change": 1, "tone": "neutral", "height": 4, "articles": 2, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "23 Jun 23:59", "short_label": "23 Jun", "collected_at": "2026-06-23T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 4, "articles": 3, "confidence": 24, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "24 Jun 23:59", "short_label": "24 Jun", "collected_at": "2026-06-24T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 4, "confidence": 21, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "27 Jun 23:59", "short_label": "27 Jun", "collected_at": "2026-06-27T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -5, "article_change": 1, "tone": "neutral", "height": 4, "articles": 5, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "29 Jun 23:59", "short_label": "29 Jun", "collected_at": "2026-06-29T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 6, "confidence": 15, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "30 Jun 23:59", "short_label": "30 Jun", "collected_at": "2026-06-30T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 7, "confidence": 15, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "01 Jul 23:59", "short_label": "01 Jul", "collected_at": "2026-07-01T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 8, "confidence": 15, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "06 Jul 23:59", "short_label": "06 Jul", "collected_at": "2026-07-06T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 11, "article_change": 1, "tone": "neutral", "height": 4, "articles": 9, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "09 Jul 23:59", "short_label": "09 Jul", "collected_at": "2026-07-09T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -8, "article_change": 1, "tone": "neutral", "height": 4, "articles": 10, "confidence": 18, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "13 Jul 23:59", "short_label": "13 Jul", "collected_at": "2026-07-13T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 11, "confidence": 15, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "15 Jul 23:59", "short_label": "15 Jul", "collected_at": "2026-07-15T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 2, "tone": "neutral", "height": 4, "articles": 13, "confidence": 14, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "16 Jul 23:59", "short_label": "16 Jul", "collected_at": "2026-07-16T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 14, "confidence": 14, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "17 Jul 23:59", "short_label": "17 Jul", "collected_at": "2026-07-17T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 15, "confidence": 14, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "21 Jul 23:59", "short_label": "21 Jul", "collected_at": "2026-07-21T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 3, "score_change_display": "+3", "confidence_change": 19, "article_change": 1, "tone": "neutral", "height": 6, "articles": 16, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "22 Jul 23:59", "short_label": "22 Jul", "collected_at": "2026-07-22T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 0, "tone": "neutral", "height": 6, "articles": 16, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "23 Jul 23:59", "short_label": "23 Jul", "collected_at": "2026-07-23T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 0, "tone": "neutral", "height": 6, "articles": 16, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "24 Jul 23:59", "short_label": "24 Jul", "collected_at": "2026-07-24T23:59:59.999999+00:00", "score": 46, "delta": -4, "score_change": -7, "score_change_display": "-7", "confidence_change": 3, "article_change": 1, "tone": "neutral", "height": 8, "articles": 17, "confidence": 35, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "25 Jul 23:59", "short_label": "25 Jul", "collected_at": "2026-07-25T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 1, "score_change_display": "+1", "confidence_change": 2, "article_change": 2, "tone": "neutral", "height": 6, "articles": 19, "confidence": 37, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "26 Jul 23:59", "short_label": "26 Jul", "collected_at": "2026-07-26T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 4, "score_change_display": "+4", "confidence_change": 1, "article_change": 2, "tone": "neutral", "height": 4, "articles": 21, "confidence": 38, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "27 Jul 23:59", "short_label": "27 Jul", "collected_at": "2026-07-27T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 22, "confidence": 37, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "28 Jul 23:59", "short_label": "28 Jul", "collected_at": "2026-07-28T23:59:59.999999+00:00", "score": 54, "delta": 4, "score_change": 3, "score_change_display": "+3", "confidence_change": 3, "article_change": 3, "tone": "neutral", "height": 8, "articles": 25, "confidence": 40, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "29 Jul 23:59", "short_label": "29 Jul", "collected_at": "2026-07-29T23:59:59.999999+00:00", "score": 54, "delta": 4, "score_change": 0, "score_change_display": "+0", "confidence_change": 8, "article_change": 13, "tone": "neutral", "height": 8, "articles": 38, "confidence": 48, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "30 Jul 23:59", "short_label": "30 Jul", "collected_at": "2026-07-30T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 3, "score_change_display": "+3", "confidence_change": 4, "article_change": 3, "tone": "neutral", "height": 14, "articles": 41, "confidence": 52, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "31 Jul 23:59", "short_label": "31 Jul", "collected_at": "2026-07-31T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 0, "tone": "neutral", "height": 14, "articles": 41, "confidence": 48, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "01 Aug 23:59", "short_label": "01 Aug", "collected_at": "2026-08-01T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -1, "score_change_display": "-1", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 12, "articles": 42, "confidence": 44, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "02 Aug 23:59", "short_label": "02 Aug", "collected_at": "2026-08-02T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 1, "score_change_display": "+1", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 14, "articles": 43, "confidence": 43, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "03 Aug 23:59", "short_label": "03 Aug", "collected_at": "2026-08-03T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -1, "score_change_display": "-1", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 12, "articles": 45, "confidence": 43, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "04 Aug 23:59", "short_label": "04 Aug", "collected_at": "2026-08-04T23:59:59.999999+00:00", "score": 55, "delta": 5, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 10, "articles": 46, "confidence": 40, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "07 Aug 23:59", "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": -3, "score_change_display": "-3", "confidence_change": -2, "article_change": 3, "tone": "neutral", "height": 4, "articles": 49, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "08 Aug 23:59", "short_label": "08 Aug", "collected_at": "2026-08-08T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 0, "tone": "neutral", "height": 4, "articles": 49, "confidence": 36, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 54, "delta": 4, "score_change": 2, "score_change_display": "+2", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 8, "articles": 51, "confidence": 36, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "11 Aug 23:59", "short_label": "11 Aug", "collected_at": "2026-08-11T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": -1, "score_change_display": "-1", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 6, "articles": 53, "confidence": 36, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "12 Aug 23:59", "short_label": "12 Aug", "collected_at": "2026-08-12T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -2, "score_change_display": "-2", "confidence_change": 5, "article_change": 2, "tone": "neutral", "height": 4, "articles": 55, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "13 Aug 23:59", "short_label": "13 Aug", "collected_at": "2026-08-13T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 2, "tone": "neutral", "height": 4, "articles": 57, "confidence": 40, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "14 Aug 23:59", "short_label": "14 Aug", "collected_at": "2026-08-14T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": -1, "tone": "neutral", "height": 4, "articles": 56, "confidence": 37, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "15 Aug 23:59", "short_label": "15 Aug", "collected_at": "2026-08-15T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": -1, "score_change_display": "-1", "confidence_change": 1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 56, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "18 Aug 23:59", "short_label": "18 Aug", "collected_at": "2026-08-18T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 2, "score_change_display": "+2", "confidence_change": -1, "article_change": 2, "tone": "neutral", "height": 4, "articles": 58, "confidence": 37, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "20 Aug 23:59", "short_label": "20 Aug", "collected_at": "2026-08-20T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -5, "article_change": 2, "tone": "neutral", "height": 4, "articles": 60, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "21 Aug 23:59", "short_label": "21 Aug", "collected_at": "2026-08-21T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 1, "score_change_display": "+1", "confidence_change": 2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 62, "confidence": 34, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "22 Aug 23:59", "short_label": "22 Aug", "collected_at": "2026-08-22T23:59:59.999999+00:00", "score": 60, "delta": 10, "score_change": 8, "score_change_display": "+8", "confidence_change": 10, "article_change": 2, "tone": "positive", "height": 20, "articles": 64, "confidence": 44, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "23 Aug 23:59", "short_label": "23 Aug", "collected_at": "2026-08-23T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -4, "score_change_display": "-4", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 12, "articles": 65, "confidence": 43, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "25 Aug 23:59", "short_label": "25 Aug", "collected_at": "2026-08-25T23:59:59.999999+00:00", "score": 55, "delta": 5, "score_change": -1, "score_change_display": "-1", "confidence_change": -7, "article_change": -3, "tone": "neutral", "height": 10, "articles": 62, "confidence": 36, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "26 Aug 23:59", "short_label": "26 Aug", "collected_at": "2026-08-26T23:59:59.999999+00:00", "score": 60, "delta": 10, "score_change": 5, "score_change_display": "+5", "confidence_change": 5, "article_change": -1, "tone": "positive", "height": 20, "articles": 61, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "27 Aug 23:59", "short_label": "27 Aug", "collected_at": "2026-08-27T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": -2, "tone": "positive", "height": 18, "articles": 59, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "01 Sep 23:59", "short_label": "01 Sep", "collected_at": "2026-09-01T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -3, "score_change_display": "-3", "confidence_change": -10, "article_change": -20, "tone": "neutral", "height": 12, "articles": 39, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "06 Sep 12:53", "short_label": "06 Sep", "collected_at": "2026-09-06T12:53:02.682665+00:00", "score": 53, "delta": 3, "score_change": -3, "score_change_display": "-3", "confidence_change": -6, "article_change": -4, "tone": "neutral", "height": 6, "articles": 35, "confidence": 22, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}], "sentiment_history_insight": {"available": true, "series_version": "evidence-v10", "live_version": "evidence-v10", "comparable_to_live": true, "reconstructed": true, "observations": 47, "span_label": "78 days", "first_score": 50, "latest_score": 53, "net_change": 3, "net_change_display": "+3", "direction": "Broadly stable", "high_score": 60, "low_score": 46, "latest_confidence": 22, "confidence_change": 22, "latest_articles": 35, "article_change": 34, "latest_label": "06 Sep 12:53", "latest_evidence_label": "Provisional", "chart_rows": [{"label": "20 Jun 23:59", "short_label": "20 Jun", "collected_at": "2026-06-20T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "neutral", "height": 4, "articles": 1, "confidence": 0, "evidence_status": "insufficient", "evidence_label": "Insufficient", "score_version": "evidence-v10", "reconstructed": true, "x": 42.0, "y": 135.0}, {"label": "22 Jun 23:59", "short_label": "22 Jun", "collected_at": "2026-06-22T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 1, "score_change_display": "+1", "confidence_change": 28, "article_change": 1, "tone": "neutral", "height": 4, "articles": 2, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 61.9, "y": 133.2}, {"label": "23 Jun 23:59", "short_label": "23 Jun", "collected_at": "2026-06-23T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 4, "articles": 3, "confidence": 24, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 81.8, "y": 133.2}, {"label": "24 Jun 23:59", "short_label": "24 Jun", "collected_at": "2026-06-24T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 4, "confidence": 21, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 101.7, "y": 133.2}, {"label": "27 Jun 23:59", "short_label": "27 Jun", "collected_at": "2026-06-27T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -5, "article_change": 1, "tone": "neutral", "height": 4, "articles": 5, "confidence": 16, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 121.7, "y": 135.0}, {"label": "29 Jun 23:59", "short_label": "29 Jun", "collected_at": "2026-06-29T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 6, "confidence": 15, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 141.6, "y": 135.0}, {"label": "30 Jun 23:59", "short_label": "30 Jun", "collected_at": "2026-06-30T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 7, "confidence": 15, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 161.5, "y": 135.0}, {"label": "01 Jul 23:59", "short_label": "01 Jul", "collected_at": "2026-07-01T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 8, "confidence": 15, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 181.4, "y": 135.0}, {"label": "06 Jul 23:59", "short_label": "06 Jul", "collected_at": "2026-07-06T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 11, "article_change": 1, "tone": "neutral", "height": 4, "articles": 9, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 201.3, "y": 135.0}, {"label": "09 Jul 23:59", "short_label": "09 Jul", "collected_at": "2026-07-09T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -8, "article_change": 1, "tone": "neutral", "height": 4, "articles": 10, "confidence": 18, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 221.2, "y": 135.0}, {"label": "13 Jul 23:59", "short_label": "13 Jul", "collected_at": "2026-07-13T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 11, "confidence": 15, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 241.1, "y": 135.0}, {"label": "15 Jul 23:59", "short_label": "15 Jul", "collected_at": "2026-07-15T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 2, "tone": "neutral", "height": 4, "articles": 13, "confidence": 14, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 261.0, "y": 135.0}, {"label": "16 Jul 23:59", "short_label": "16 Jul", "collected_at": "2026-07-16T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 14, "confidence": 14, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 281.0, "y": 135.0}, {"label": "17 Jul 23:59", "short_label": "17 Jul", "collected_at": "2026-07-17T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 15, "confidence": 14, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 300.9, "y": 135.0}, {"label": "21 Jul 23:59", "short_label": "21 Jul", "collected_at": "2026-07-21T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 3, "score_change_display": "+3", "confidence_change": 19, "article_change": 1, "tone": "neutral", "height": 6, "articles": 16, "confidence": 33, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 320.8, "y": 129.5}, {"label": "22 Jul 23:59", "short_label": "22 Jul", "collected_at": "2026-07-22T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 0, "tone": "neutral", "height": 6, "articles": 16, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 340.7, "y": 129.5}, {"label": "23 Jul 23:59", "short_label": "23 Jul", "collected_at": "2026-07-23T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 0, "tone": "neutral", "height": 6, "articles": 16, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 360.6, "y": 129.5}, {"label": "24 Jul 23:59", "short_label": "24 Jul", "collected_at": "2026-07-24T23:59:59.999999+00:00", "score": 46, "delta": -4, "score_change": -7, "score_change_display": "-7", "confidence_change": 3, "article_change": 1, "tone": "neutral", "height": 8, "articles": 17, "confidence": 35, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 380.5, "y": 142.3}, {"label": "25 Jul 23:59", "short_label": "25 Jul", "collected_at": "2026-07-25T23:59:59.999999+00:00", "score": 47, "delta": -3, "score_change": 1, "score_change_display": "+1", "confidence_change": 2, "article_change": 2, "tone": "neutral", "height": 6, "articles": 19, "confidence": 37, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 400.4, "y": 140.5}, {"label": "26 Jul 23:59", "short_label": "26 Jul", "collected_at": "2026-07-26T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 4, "score_change_display": "+4", "confidence_change": 1, "article_change": 2, "tone": "neutral", "height": 4, "articles": 21, "confidence": 38, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 420.3, "y": 133.2}, {"label": "27 Jul 23:59", "short_label": "27 Jul", "collected_at": "2026-07-27T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 22, "confidence": 37, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 440.3, "y": 133.2}, {"label": "28 Jul 23:59", "short_label": "28 Jul", "collected_at": "2026-07-28T23:59:59.999999+00:00", "score": 54, "delta": 4, "score_change": 3, "score_change_display": "+3", "confidence_change": 3, "article_change": 3, "tone": "neutral", "height": 8, "articles": 25, "confidence": 40, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 460.2, "y": 127.7}, {"label": "29 Jul 23:59", "short_label": "29 Jul", "collected_at": "2026-07-29T23:59:59.999999+00:00", "score": 54, "delta": 4, "score_change": 0, "score_change_display": "+0", "confidence_change": 8, "article_change": 13, "tone": "neutral", "height": 8, "articles": 38, "confidence": 48, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 480.1, "y": 127.7}, {"label": "30 Jul 23:59", "short_label": "30 Jul", "collected_at": "2026-07-30T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 3, "score_change_display": "+3", "confidence_change": 4, "article_change": 3, "tone": "neutral", "height": 14, "articles": 41, "confidence": 52, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 500.0, "y": 122.3}, {"label": "31 Jul 23:59", "short_label": "31 Jul", "collected_at": "2026-07-31T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 0, "score_change_display": "+0", "confidence_change": -4, "article_change": 0, "tone": "neutral", "height": 14, "articles": 41, "confidence": 48, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 519.9, "y": 122.3}, {"label": "01 Aug 23:59", "short_label": "01 Aug", "collected_at": "2026-08-01T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -1, "score_change_display": "-1", "confidence_change": -4, "article_change": 1, "tone": "neutral", "height": 12, "articles": 42, "confidence": 44, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 539.8, "y": 124.1}, {"label": "02 Aug 23:59", "short_label": "02 Aug", "collected_at": "2026-08-02T23:59:59.999999+00:00", "score": 57, "delta": 7, "score_change": 1, "score_change_display": "+1", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 14, "articles": 43, "confidence": 43, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 559.7, "y": 122.3}, {"label": "03 Aug 23:59", "short_label": "03 Aug", "collected_at": "2026-08-03T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -1, "score_change_display": "-1", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 12, "articles": 45, "confidence": 43, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 579.7, "y": 124.1}, {"label": "04 Aug 23:59", "short_label": "04 Aug", "collected_at": "2026-08-04T23:59:59.999999+00:00", "score": 55, "delta": 5, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 10, "articles": 46, "confidence": 40, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 599.6, "y": 125.9}, {"label": "07 Aug 23:59", "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": -3, "score_change_display": "-3", "confidence_change": -2, "article_change": 3, "tone": "neutral", "height": 4, "articles": 49, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 619.5, "y": 131.4}, {"label": "08 Aug 23:59", "short_label": "08 Aug", "collected_at": "2026-08-08T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 0, "tone": "neutral", "height": 4, "articles": 49, "confidence": 36, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 639.4, "y": 131.4}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 54, "delta": 4, "score_change": 2, "score_change_display": "+2", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 8, "articles": 51, "confidence": 36, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 659.3, "y": 127.7}, {"label": "11 Aug 23:59", "short_label": "11 Aug", "collected_at": "2026-08-11T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": -1, "score_change_display": "-1", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 6, "articles": 53, "confidence": 36, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 679.2, "y": 129.5}, {"label": "12 Aug 23:59", "short_label": "12 Aug", "collected_at": "2026-08-12T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -2, "score_change_display": "-2", "confidence_change": 5, "article_change": 2, "tone": "neutral", "height": 4, "articles": 55, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 699.1, "y": 133.2}, {"label": "13 Aug 23:59", "short_label": "13 Aug", "collected_at": "2026-08-13T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 2, "tone": "neutral", "height": 4, "articles": 57, "confidence": 40, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 719.0, "y": 135.0}, {"label": "14 Aug 23:59", "short_label": "14 Aug", "collected_at": "2026-08-14T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": -1, "tone": "neutral", "height": 4, "articles": 56, "confidence": 37, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 739.0, "y": 135.0}, {"label": "15 Aug 23:59", "short_label": "15 Aug", "collected_at": "2026-08-15T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": -1, "score_change_display": "-1", "confidence_change": 1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 56, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 758.9, "y": 136.8}, {"label": "18 Aug 23:59", "short_label": "18 Aug", "collected_at": "2026-08-18T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 2, "score_change_display": "+2", "confidence_change": -1, "article_change": 2, "tone": "neutral", "height": 4, "articles": 58, "confidence": 37, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 778.8, "y": 133.2}, {"label": "20 Aug 23:59", "short_label": "20 Aug", "collected_at": "2026-08-20T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -5, "article_change": 2, "tone": "neutral", "height": 4, "articles": 60, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 798.7, "y": 133.2}, {"label": "21 Aug 23:59", "short_label": "21 Aug", "collected_at": "2026-08-21T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 1, "score_change_display": "+1", "confidence_change": 2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 62, "confidence": 34, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 818.6, "y": 131.4}, {"label": "22 Aug 23:59", "short_label": "22 Aug", "collected_at": "2026-08-22T23:59:59.999999+00:00", "score": 60, "delta": 10, "score_change": 8, "score_change_display": "+8", "confidence_change": 10, "article_change": 2, "tone": "positive", "height": 20, "articles": 64, "confidence": 44, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 838.5, "y": 116.8}, {"label": "23 Aug 23:59", "short_label": "23 Aug", "collected_at": "2026-08-23T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -4, "score_change_display": "-4", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 12, "articles": 65, "confidence": 43, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 858.4, "y": 124.1}, {"label": "25 Aug 23:59", "short_label": "25 Aug", "collected_at": "2026-08-25T23:59:59.999999+00:00", "score": 55, "delta": 5, "score_change": -1, "score_change_display": "-1", "confidence_change": -7, "article_change": -3, "tone": "neutral", "height": 10, "articles": 62, "confidence": 36, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 878.3, "y": 125.9}, {"label": "26 Aug 23:59", "short_label": "26 Aug", "collected_at": "2026-08-26T23:59:59.999999+00:00", "score": 60, "delta": 10, "score_change": 5, "score_change_display": "+5", "confidence_change": 5, "article_change": -1, "tone": "positive", "height": 20, "articles": 61, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 898.3, "y": 116.8}, {"label": "27 Aug 23:59", "short_label": "27 Aug", "collected_at": "2026-08-27T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": -2, "tone": "positive", "height": 18, "articles": 59, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true, "x": 918.2, "y": 118.6}, {"label": "01 Sep 23:59", "short_label": "01 Sep", "collected_at": "2026-09-01T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -3, "score_change_display": "-3", "confidence_change": -10, "article_change": -20, "tone": "neutral", "height": 12, "articles": 39, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 938.1, "y": 124.1}, {"label": "06 Sep 12:53", "short_label": "06 Sep", "collected_at": "2026-09-06T12:53:02.682665+00:00", "score": 53, "delta": 3, "score_change": -3, "score_change_display": "-3", "confidence_change": -6, "article_change": -4, "tone": "neutral", "height": 6, "articles": 35, "confidence": 22, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true, "x": 958.0, "y": 129.5}], "chart_points": "42.0,135.0 61.9,133.2 81.8,133.2 101.7,133.2 121.7,135.0 141.6,135.0 161.5,135.0 181.4,135.0 201.3,135.0 221.2,135.0 241.1,135.0 261.0,135.0 281.0,135.0 300.9,135.0 320.8,129.5 340.7,129.5 360.6,129.5 380.5,142.3 400.4,140.5 420.3,133.2 440.3,133.2 460.2,127.7 480.1,127.7 500.0,122.3 519.9,122.3 539.8,124.1 559.7,122.3 579.7,124.1 599.6,125.9 619.5,131.4 639.4,131.4 659.3,127.7 679.2,129.5 699.1,133.2 719.0,135.0 739.0,135.0 758.9,136.8 778.8,133.2 798.7,133.2 818.6,131.4 838.5,116.8 858.4,124.1 878.3,125.9 898.3,116.8 918.2,118.6 938.1,124.1 958.0,129.5", "changes": [{"label": "06 Sep 12:53", "short_label": "06 Sep", "collected_at": "2026-09-06T12:53:02.682665+00:00", "score": 53, "delta": 3, "score_change": -3, "score_change_display": "-3", "confidence_change": -6, "article_change": -4, "tone": "neutral", "height": 6, "articles": 35, "confidence": 22, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "01 Sep 23:59", "short_label": "01 Sep", "collected_at": "2026-09-01T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -3, "score_change_display": "-3", "confidence_change": -10, "article_change": -20, "tone": "neutral", "height": 12, "articles": 39, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}, {"label": "27 Aug 23:59", "short_label": "27 Aug", "collected_at": "2026-08-27T23:59:59.999999+00:00", "score": 59, "delta": 9, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": -2, "tone": "positive", "height": 18, "articles": 59, "confidence": 38, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "26 Aug 23:59", "short_label": "26 Aug", "collected_at": "2026-08-26T23:59:59.999999+00:00", "score": 60, "delta": 10, "score_change": 5, "score_change_display": "+5", "confidence_change": 5, "article_change": -1, "tone": "positive", "height": 20, "articles": 61, "confidence": 41, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "25 Aug 23:59", "short_label": "25 Aug", "collected_at": "2026-08-25T23:59:59.999999+00:00", "score": 55, "delta": 5, "score_change": -1, "score_change_display": "-1", "confidence_change": -7, "article_change": -3, "tone": "neutral", "height": 10, "articles": 62, "confidence": 36, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "23 Aug 23:59", "short_label": "23 Aug", "collected_at": "2026-08-23T23:59:59.999999+00:00", "score": 56, "delta": 6, "score_change": -4, "score_change_display": "-4", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 12, "articles": 65, "confidence": 43, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "22 Aug 23:59", "short_label": "22 Aug", "collected_at": "2026-08-22T23:59:59.999999+00:00", "score": 60, "delta": 10, "score_change": 8, "score_change_display": "+8", "confidence_change": 10, "article_change": 2, "tone": "positive", "height": 20, "articles": 64, "confidence": 44, "evidence_status": "measured", "evidence_label": "Measured", "score_version": "evidence-v10", "reconstructed": true}, {"label": "21 Aug 23:59", "short_label": "21 Aug", "collected_at": "2026-08-21T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 1, "score_change_display": "+1", "confidence_change": 2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 62, "confidence": 34, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v10", "reconstructed": true}]}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}